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Abstract 
While titanium (Ti) and its alloys have become ubiquitous within implantology as materials to 
restore or augment the function of human tissues, their success is plagued by complications 
associated with infection and aseptic implant loosening. These two risks account for the majority 
of implant failures in the clinic and limit the long-term success of titanium implants in vivo. 
Therefore, this thesis describes the development of robust multifunctional class II organic-
inorganic hybrid coating materials for titanium implants that could be used to effectively target 
both complications, concurrently. During this master’s work, two different coating systems were 
examined. First, class II hybrid coating materials composed of chitosan and silica loaded with 
silver nanoparticles were investigated. These coatings displayed a high resistance to fracture, 
great substrate adhesion and inhibited the growth of two clinically relevant pathogenic bacteria 
(E. coli and S. aureus) in both biofilm and planktonic cultures. Secondly, a novel class II hybrid 
coating material was developed that was composed of polyethylene glycol, calcium, and silica 
and loaded with silver nanoparticles. This hybrid bioactive glass material possessed similar 
mechanical and antimicrobial properties to the chitosan-silica coatings and displayed an 
increased bioactive response. From this study, a better understanding of the feasibility of class II 
hybrid materials as implant coatings was developed. The work presented in this work may afford 
a novel strategy in improving the success of implants for biomedical applications. 
Keywords 
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Summary for Lay Audience 
The use of titanium implant materials has become ubiquitous in the field of implantology. While 
titanium-based implant materials possess adequate mechanical properties to meet the demanding 
loading conditions of the human body, their interfaces fail to illicit positive physiological 
responses. For this reason, implant surfaces become targeted sites for microbial colonization 
(leading to infections) and are unable to promote the fixation of protheses (leading to loosening) 
in the body. These phenomena (implant associated infection and aseptic loosening, respectively) 
are the two major complications that affect the continued success of hard tissue restorations 
today.  
In consideration of these complications, this study provides a potential coating solution that can 
synergistically prevent infection and promote the fixation of implantable materials. Using a 
coating framework composed of similar inorganic contents to that of bone, positive physiological 
responses can be promoted that encourage the fixation of the implantable devices within hard 
tissues. By imbedding coating networks with antimicrobial silver nanoparticles, implant surfaces 
could be afforded with infection-resistant properties.  
This study also considered the factors attributed to the clinical translatability of developed 
“multifunctional” implant coatings. Coating materials developed for hard tissue implants should 
be robust. This means they remain adhered to the implant surface throughout its lifetime within 
the body and are resistant to the impacts of various surgical tools and bony protrusions upon 
implantation. Additionally, such coating materials should avoid the use of toxic chemicals or 
network forming agents. This ensures that during the lifetime of the implant potential coating 
degradation does not induce a toxic effect in the host.  
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Chapter 1: Introduction 
1.1 Overview 
An implantable material (or biomaterial) is a biomedical device used to augment or restore the 
function of human tissues. Over the past fifty years, the popularity of biomaterial-based 
treatments has increased dramatically with more than 13 million devices implanted annually in 
the United States alone1. Through advances in material science, biomaterials have become 
increasingly tailorable to human physiology. This has led to a considerable increase in the 
success of such materials in the replacement of damaged bone tissues.    
Throughout this past half century, titanium (Ti) and its alloys have become the material of choice 
for biomedical implants2,3. Their low specific weight, high strength to weight ratio, and 
resistance to corrosion are features that make titanium the ideal bulk material for numerous 
clinical applications4,5. These include orthopaedic and dental implants where their resistance to 
chipping and capacity to endure repetitive high loading conditions are an advantage over non-
metallic substrates4,6,7. Furthermore, the titanium dioxide layer that forms on their surfaces are 
highly inert and biocompatible to the cells and extracellular matrix of surrounding tissues. 
However, along with the bio-inertia of titanium surfaces, is the lack of significant osteoinductive 
or antimicrobial properties. 
Currently, the surface modifications on titanium implants are limited commercially to surface 
treatments (physical roughening, anodizing, chemical etching etc.), and inorganic ceramic 
coatings that typically incorporate hydroxyapatite (HA) as a bioactive layer. However, the 
application of ceramic coatings involves numerous disadvantages such as slow processes, high 
temperatures (biomimetism, plasma spraying), overly thick or weak film deposition, brittle 
substrates, and their inability to be loaded with temperature sensitive antimicrobials8–10. 
Therefore, there has been significant interest in using alternative coating materials that consist of 
a larger organic content, which would improve their material properties while retaining an 
adequate level of bioactivity in tissues. 
Given the limited success of commercially available coating materials, the development of 
multifunctional implant coatings, capable of providing osteoconductive interactions with native 
interfaces while also providing antimicrobial activity have been increasingly sought after. To this 
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end, the development of class II organic-inorganic hybrid materials that retain the biological 
benefits of polymers such as chitosan and PEG, while enhancing their physical properties, has 
been proposed11–13. The covalent coupling of biopolymers to inorganic precursors is the focus of 
this thesis and is the framework of multifunctional coating materials evaluated in this study.  
1.2 Thesis Objectives 
Considering the limited success of bare and plasma coated titanium implant materials, the overall 
focus of this study was to synthesize robust coating materials on titanium substrates to improve 
on their overall success in vivo. Coatings developed in this work should greatly improve on the 
shortcomings of current bare and plasma coated titanium implant materials.   
1.3 Hypothesis 
It is hypothesized that the integration of silicon (Si) and calcium (Ca) into the coating network 
will act to improve the overall robustness of coating materials, and, will promote factors 
associated with osseointegration. Additionally, it is hypothesized that the addition of silver 
nanoparticles (AgNP) into the coating network will provide an antimicrobial effect against 
sessile and biofilm colonies of clinically relevant pathogenic bacteria.   
1.4 Thesis Outline 
As highlighted above, the objectives and hypothesis of this study focuses on the development of 
robust bioactive and antibacterial coating materials for titanium implantable devices. Chapter 2 
provides a comprehensive review of the relevant literature in this area. Chapter 3 includes the 
synthesis and discussion of a robust chitosan-silicon class II hybrid coating materials to improve 
the antimicrobial efficacy of titanium implants. Chapter 4 includes the synthesis and relevant 
discussions related to the development of a robust PEG-Si-Ca class II hybrid coating to promote 
osseointegration while providing an antimicrobial effect. Chapter 5 provides a discussion on the 
relevant conclusions to this study and suggestions for future work. 
1.5 References 
(1)  Wang, X. Overview on Biocompatibilities of Implantable Biomaterials. In Advances in 
Biomaterials Science and Biomedical Applications; InTech, 2013. 
(2)  Saini, M. Implant Biomaterials: A Comprehensive Review. World J. Clin. Cases 2015, 3 
(1), 52. 
(3)  Van Noort, R. Titanium: The Implant Material of Today. J. Mater. Sci. 1987, 22 (11), 
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3801–3811. 
(4)  Özcan, M.; Hämmerle, C. Titanium as a Reconstruction and Implant Material in Dentistry: 
Advantages and Pitfalls. Materials (Basel). 2012, 5 (9), 1528–1545. 
(5)  Greger, M.; Widomská, M.; Snášel, V. Structure and Properties of Dental Implants. In 
METAL 2012 - Conference Proceedings, 21st International Conference on Metallurgy 
and Materials; 2012; Vol. 120, pp 434–439. 
(6)  Raigrodski, A. J.; Hillstead, M. B.; Meng, G. K.; Chung, K. H. Survival and 
Complications of Zirconia-Based Fixed Dental Prostheses: A Systematic Review. J. 
Prosthet. Dent. 2012, 107 (3), 170–177. 
(7)  Niinomi, M. Mechanical Biocompatibilities of Titanium Alloys for Biomedical 
Applications. J. Mech. Behav. Biomed. Mater. 2008, 1 (1), 30–42. 
(8)  Ong, J. L.; Lucas, L. C. Post-Deposition Heat Treatments for Ion Beam Sputter Deposited 
Calcium Phosphate Coatings. Biomaterials 1994, 15 (5), 337–341. 
(9)  Li, T.; Lee, J.; Kobayashi, T.; Aoki, H. Hydroxyapatite Coating by Dipping Method, and 
Bone Bonding Strength. J. Mater. Sci. Mater. Med. 1996, 7 (6), 355–357. 
(10)  Wang, B. C.; Lee, T. M.; Chang, E.; Yang, C. Y. The Shear Strength and the Failure 
Mode of Plasma-Sprayed Hydroxyapatite Coating to Bone: The Effect of Coating 
Thickness. J. Biomed. Mater. Res. 1993, 27 (10), 1315–1327. 
(11)  Tian, D.; Dubois, P.; Jérôme, R. Biodegradable and Biocompatible Inorganic-Organic 
Hybrid Materials. I. Synthesis and Characterization. J. Polym. Sci. Part A Polym. Chem. 
1997, 35 (11), 2295–2309. 
(12)  Valliant, E. M.; Jones, J. R. Softening Bioactive Glass for Bone Regeneration: Sol-Gel 
Hybrid Materials. Soft Matter 2011, 7 (11), 5083–5095. 
(13)  Sachot, N.; Castaño, O.; Mateos-Timoneda, M. A.; Engel, E.; Planell, J. A. Hierarchically 
Engineered Fibrous Scaffolds for Bone Regeneration. J. R. Soc. Interface 2013, 10 (88), 
2–6. 
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Chapter 2: Literature Review and Background 
While established as a field of scientific study in the 1960s, the use of biomaterials pre-dates 
ancient times. Evidence of foreign material usage as implants or protheses has been found in the 
excavation of ancient burial sites of ancient Egyptian, Roman, Greek and Etruscan civilizations1. 
Since these primitive designs, biomaterial implementation has been improved through 
industrialization, advances in material and polymer chemistry, and an increased understanding of 
the foreign body response to biomaterials.  
2.1 Hard Tissue Implants 
Since antiquity, hard tissue implants have found great use in the restoration and augmentation of 
diseased or damaged tissues. In general, hard tissue implants are prosthesis that are integrated 
with hard tissue systems in the body such as bones, joints, and teeth. In present day, these 
prostheses are predominantly made of metallic or ceramic materials that have sufficient chemical 
and mechanical stability to achieve successful integration and long-term stability with host 
tissues. The application of hard tissue implant materials finds greatest use in the fields of 
orthopedics and prosthodontics.  
Orthopedic implants exist in many physical forms and can be used in a variety of restorations 
such as joint arthroplasty (hip, knee, and shoulder) and the repair of fractures to other osseous 
tissues (some shown in Figure 2.1)2. Surgical interventions and implantations have become 
increasingly more common in this area due to the increased rates of osteoporosis and arthritis 
among older populations2,3. Often large orthopedic restorative surgeries, such as total hip 
replacements, require special attention to the type of implant materials used. Consideration for 
material properties such as elastic modulus, hardness, and fatigue resistance have been shown to  
prevent long term complications associated with these load bearing implants such as stress 
shielding and wear3,4. Other devices used in orthopedics include small, and non- or low-load 
bearing implant materials that include screws, pins, plates and meshes. These materials are often 
used as internal or external fixation devices which can maintain the alignment of bone fragments 
or material substitutes during the healing process5. During the application of these fixation 
devices, compressive force is often used to lower stresses placed on the implant and increase the 
contact area at repair sites5. Given that these devices are under significantly lower stresses than 
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larger orthopedic implants, procedural complications are more frequently associated with 
infection rather than stress shielding and wear.  
 
 
Figure 2.1 Examples of implant forms used for hard tissue implantation in orthopedics. Adapted 
from Rony et al.6 
In prosthodontics, dental implants are most commonly used as supports for artificial tooth 
replacements. The use of dental implants has increased dramatically in the past 30 years, limiting 
the need for non-fixed dentures and bridges to replace lost teeth in many cases7. Implants in this 
field exist in a variety of physical forms such as screws, cylinders and blades, with the most 
common structure of complete dental prosthesis following a screw-abutment-crown design 
(Figure 2.2)8. Here, screw-like devices are directly implanted into the maxilla or mandible which 
acts as an anchor for artificial teeth (crowns). Abutments are then used to connect the crown to 
the screw anchored in the patient’s jawbone9,10. Similar to the field of orthopedics, dental 
implants are used for both load bearing and low-load bearing applications which are determined 
by their placement in the oral cavity11. The success of these implants is determined by the 
successful fixation of screw supports implanted within the jawbone and their ability to resist 
infection. Failure modes of these implants have been attributed to low bone density in the 
maxillofacial region and implant sepsis due to the contaminated surgical field within the oral 
cavity12,13.  
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Figure 2.2 Screw-abutment-crown dental implant design. Adapted from 
www.1888implant.com14 
In both orthopedic and prosthodontic implant interventions, the choice of material is a critical 
determinant to the overall success of the restoration. Titanium represents a large portion of these 
bone-interfacing biomaterials given its superior mechanical properties and proven ability to 
interface well with human tissues.   
 
2.1.1 Titanium Implants 
Metallics have been the choice implant material since the advent of aseptic surgical techniques15. 
Since then, metallics have found many uses as orthopedic and prosthodontic implant materials. 
Commonly used metallics in these areas include stainless steel (SS), cobalt-chromium alloys 
(CoCr), and titanium alloys (Ti). Of which, SS and CoCr have lost favour in many applications 
due to their lack of performance in comparison to titanium alloys. Titanium based implants 
possesses advantages over these metallics in terms of their rate of corrosion, modulus value, and 
biocompatibility.   
The corrosion of metallic implants leads to the release of metallic ions from the bulk material.  
The release of these cationic species affects surrounding tissues by modifying their electrical and 
chemical environment which can produce a degree of cytotoxicity16,17. While all metals corrode 
to some extent in vivo, choice materials are those that corrode in a slow and controlled fashion18. 
For this reason, SS and CoCr implant materials have lost favour in many applications as they 
readily corrode in physiological environments. The corrosion of SS an CoCr, along with 
modifying the surrounding physiological environment, leads to a cytotoxic effect attributed to 
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the leaching of cytotoxic elements such as nickel, chromium and cobalt19. Titanium based 
materials, however, exhibit a high resistance to corrosion. Additionally, when alloyed, titanium 
based materials can contain relatively non-toxic elements such as magnesium niobium, tantalum, 
and zirconium leading to minimal cytotoxicity during corrosion20,21. Titanium and titanium 
alloys display increased resilience to corrosion due to the formation of an oxide layer in the form 
of TiO2, Ti2O3, TiO and TiO2
22,23. This film, while robust, also possesses self healing properties 
in vivo due to the reactive nature of titanium. Any disruptions or damages to the outer oxide layer 
are repaired immediately in environments with air or oxidizing media such as physiological 
fluids. 
 
Additionally, SS and CoCr based implant materials have relatively high modulus values 
compared to that of bone (Figure 2.3)24. High modulus mismatches between implant materials 
and host bony tissues have been shown to cause a condition known as stress shielding. Stress 
shielding is a process in which high modulus implant materials prevent host tissues from being 
exposed to normal levels of mechanical loading25. In cases where stress shielding occurs, host 
bony tissues around the implant are remodeled, leading to a decrease in bone strength, cell death, 
and subsequent implant loosening26,27. Unlike SS and CoCr materials, titanium alloys can 
possess similar moduli to that of bone, leading to a decrease in the severity of stress shielding. 
The decreased effect of stress shielding becomes quite relevant in the comparison of different 
metallics used as high load bearing implant materials. In the case of total hip replacements, 
studies have shown that femoral stem materials made of titanium alloys, as opposed to higher 
modulus materials such as CoCr and SS, led to less femoral bone loss and better integration with 
host tissues28–30.   
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Figure 2.3 Modulus of elasticity of commonly used implant metallics. Adapted from 
Geetha et al.24 
 
In addition to being more resistant to corrosion and possessing improved mechanical properties 
to other metallics, titanium materials are also more biocompatible. While no surgical study of 
metallic implants is completely free of adverse reactions, titanium implant materials have been 
shown to be well tolerated as an inert material in the human body. When compared to SS and 
CoCr alloys, titanium implant materials exhibit superior biocompatibility, akin to their decreased 
cytotoxicity and decreased levels of fibrosis upon implantation20,24,31. The increase in relative 
cytotoxicity and fibrosis of SS and CoCr implant materials have been owed to the release of 
metal ions upon corrosion and their lack of relevant topographical cues32,33. 
Despite the superior performance of titanium-based implant materials relative to other metallics, 
they are still continuously subjected to various surface modifications in order to better function 
with the human body. The development of appropriate surface topographies and coating 
materials has represented a large portion of research in implantology in recent years and has been 
a challenging problem in the field of metallics in general. The interface of implant materials has 
become a key factor to combat the complications faced in this field and, overall, increase the 
longevity and fixation of implants in the human body32,34–36. 
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2.1.2 Implant Complications  
2.1.2.1 Implant Associated Infections 
One of the main problems that continues to limit the success of hard tissue implant interventions 
is implant associated infection (IAI). Orthopedic fixation devices, particularly external fixation 
devices, have notoriously high rates of post-operative infection, occurring in 5 and 30% of all 
internal and external interventions respectively37,38. The infections of dental implants are also 
significant with IAI occurring in 5-10% of all implant procedures39. While virtually all bacteria 
and fungi can cause IAI, the most common bacteria responsible are the staphylococci species 
including Staphylococcus aureus (S. Aureus) and Staphylococcus epidermidis (S. 
epidermidis)40,41. The prevalence of such species can be owed to their natural residence within 
the skin flora and their ability to form pathogenic biofilms on implant surfaces42.  
 
Biofilms are highly adherent colonies of bacteria that are encased within a bacterial-excreted 
polysaccharide matrix. The formation of biofilms occurs through several stages explained 
visually through Figure 2.4. In this process, planktonic species of bacteria adhere to a surface and 
then begin to proliferate and adhere to adjacent colonies through the release of extracellular 
polymeric substances (EPS). Mature biofilms encased in EPS subsequently release planktonic 
colonies within their matrix to continue the cycle. Additionally, mature biofilms present a 
favourable environment for symbiotic microbes such as Escherichia coli and Pseudomonas 
aeruginosa in the development of polymicrobial biofilms43. The formation of biofilms presents 
major problems in combating IAI. First, the release of planktonic colonies from mature biofilms 
leads to a chronic inflammatory state at the implant site, and, can lead to infection in other parts 
of the body. Second, the bacteria within biofilms may be up to 1000 times more resistant to 
antibiotics than bacteria that are suspended in a planktonic state44,45. In the antibiotic therapy of 
biofilm infections, the high doses of antibiotics required to combat biofilms result in systemic 
toxicity with associated renal and liver complications46,47. When low dose treatments are used, 
therapeutic agents are often below the minimum inhibitory concentration (MIC) of biofilm 
bound bacteria which increases the risk of developing antibiotic resistance pathogens48.  
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Figure 2.4 Stages of biofilm formation on implant surfaces. Adapted from Chung et al.49  
 
Due to the resistant nature of biofilms, the gold standard treatment of IAIs in orthopedics has 
been two-stage septic revisions50. In this revision technique, the first stage involves the removal 
of the prosthesis, followed by extensive debridement of all damaged or infected tissues. At this 
stage, antibiotics are administered to patients and reimplantation is delayed until the completion 
of an antibiotic regimen. In conjunction with this regimen, antibiotic-loaded beads or spacers are 
typically inserted into the sites of larger infected prosthesis such as those used in total hip and 
knee replacements51. Reimplantation in these cases includes the removal of antibiotic-loaded 
beads or spacers before the placement of the new prosthesis. Septic revisions are technically 
complex and require significantly more resources than initial prosthesis placements4. The 
duration of these surgeries are longer, patient hospital stays are extended, and there are often 
more complications related to these interventions. Despite this rigorous procedure, the initial 
infection is not always completely eradicated which increases the chance of reinfection at the site 
of reimplantation52. For example, in the case of total hip arthroplasty (THA), there is typically a 
1-2% risk of infection for primary THA, whereas secondary septic revisions of THA carry risks 
of infections as high as 17%51,53,54. 
 
In the field of prosthodontics, IAIs are typically caused by the colonization of pathogenic 
biofilms on the collar of dental implants. Biofilm formation on dental implant materials can 
initially lead to infections of the peri-implant mucosa in a condition known as peri-implant 
mucositis (PIM)55. PIM, which causes inflammation and damage of the peri-implant mucosa, 
ultimately leads to the formation of soft tissue gaps around the implant. The formation of these 
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gaps allows for bacteria to spread to regions where hard tissues are exposed. The exposure of 
pathogenic bacteria to surrounding bone causes characteristic bone loss around the implant in a 
condition known as peri-implantitis (PI)56. PI has been shown to be one of the main reasons for 
the loosening and failure of dental implants57. Due to the placement of dental implants in 
endosseous tissues and the prevalence of biofilm occurring mainly at the collar of dental 
abutments, treatment methods typically do not follow the same septic two-stage revisions seen in 
the field of orthopedics. In the treatment of dental implant infections a variety of surgical 
(resective therapy, bone regeneration therapy) and non-surgical methods (abrasive cleaning, 
ultrasonic decontamination) are employed on a case to case basis58,59. The efficacy of different 
treatment methods is debated frequently, with their success remaining variable over long-term 
studies60. One of the main reasons for this variability is the difficulty in managing PIM. The 
continuation of PIM, as described above, leads to PI which is typically not responsive to non-
surgical interventions56,61,62. The failure to effectively treat infected dental implants and their 
environment have led to increased rates of reinfection. While the risk of initial post-periodontal 
infection is ~4%, the risk of reinfection or continued peri-implantitis 3-7 years after revision 
treatments ranges from 16-25%63–65. 
 
Due to the resistant nature of biofilms, IAIs have become one of the most common causes of 
revisited surgeries and implant removal40,66,67. Efforts to mitigate the prevalence of biofilms on 
implant surfaces have, to this point, showed mild effectiveness at eliminating the risks of post-
operative infection. More specifically, the use of prophylactic antibiotic regimens has remained 
minimally effective at targeting developed biofilms and fails to accommodate the continued risks 
of infection throughout the lifetime of integrated implants. Therefore, the use of site-specific 
antimicrobial action that can retard the formation of biofilms, or, provide a localized release of 
biocidal components provides an attractive alternative in the treatment and mitigation of IAI.  
 
2.1.2.2 Aseptic Loosening 
While IAI remains the primary reason for the failure of most hard tissue implants, the loosening 
of implants without the presence of microbial infection presents another clinically relevant issue. 
Aseptic loosening is a result of the inability of an implant surface to bond to adjacent bone and 
other tissues68. This lack of fixation leads to micromotions of the prosthesis which causes the 
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formation of fibrous tissues arounds the implant, and subsequent loosening from the site of 
implantation.  
In the field of orthopedics, aseptic loosening is a major complication and is the cause of more 
than 52% of hip arthroplasty revisions in the US annually69. Here, aseptic loosening typically 
occurs following the release of particulate debris around the site of implantation. Particulate 
debris can develop around the implant site from a variety of origins such as: poor surgical 
technique, the loss of mechanically fixed bone cement, or wear at polymer-metal interfaces3,68. 
The formation of wear debris leads to an elevated inflammatory response, bone resorption, and 
osteolysis, leading to loosening and subsequent implant loss70. Unsurprisingly, aseptic failures 
often require surgical revisions which include the complete removal and replacement of the 
initial prosthesis with site re-debridement leading to significant losses in surrounding tissues. 
Surgical revisions, in addition to increased hospital times for patients, carry increased risks for 
additional failures following replacements. In a study following aseptic total knee arthroplasty 
(TKA) revisions, 10% of revisions failed with majority of the causes being attributed to a 
continued state of instability and IAI71.  
Due to the lack of articulation between implant features and their decreased loads, the modes of 
aseptic failure in the field of prosthodontics are not often attributed to the presence of particulate 
debris. Instead, aseptic failures of dental implants are often attributed to poor bone quantity, poor 
bone quality, and/or a lack of primary stability72. These factors can lead to excessive micro- and 
macro-motion at the bone-implant interface which promotes the development of a fibrous tissue 
membrane around the implant, subsequently leading to aseptic loosening and eventual failure73. 
The absence of bone in these cases is often described by clinicians as marginal bone loss and is 
frequently monitored throughout the lifetime of dental implants using radiographs. While this 
method does allow for implant stability to be monitored over time, lack of patient compliance, 
radiographic accuracy, and non-surgical interventions limit treatment efficacy73,74. Dental 
implants that fail through aseptic modes are often replaced through the complete removal of the 
initial implant, followed by either a 1 year wait period for the replacement of a similar screw 
fixture, or, immediate replacement of a larger diameter screw fixture that removes the threading 
and tissues surrounding the initial site72. In either case, these revisions in sites of aseptic failure 
have show mild success with risks of failure up to 30%75,76.  
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As with IAI, aseptic loosening remains a clinical concern where often invasive treatment 
methods must be used at the burden of patient comfort and economic efficiency. Similarly, to 
mitigate the potential for aseptic loosening events, surface systems that are targeted to improve 
the fixation of hard tissue implants can afford a variety of advantages. Details of these systems, 
as well as the interrelation of coating systems to target both complications will be highlighted in 
the following sections of this literature review.  
2.2 Implant Surface Modifications 
Current strategies to mitigate the complications associated with IAI and aseptic loosening have 
relied mainly on implant surface modifications. Although titanium possesses a robust and stable 
film, its inert nature limits its ability to battle infections or promote long-term bonds with bone. 
Herein, surface modifications to mitigate IAIs and aseptic loosening will be discussed.  
2.2.1 Antibacterial Surfaces 
As previously discussed, the treatment of IAIs and the formation of biofilms on implant surfaces 
have shown minimal success and often present increased risks of continued infection. Given the 
increased resistance of biofilms to systemic antibiotic regimens, surface modifications have 
emerged as popular method to provide hard tissue implant materials with antibacterial properties. 
Antibacterial surface treatments often act by preventing the primary adhesion of planktonic 
bacteria to implant surfaces, or, by killing approaching bacteria. These two major approaches can 
be summarized within non-eluting, eluting, and combination antibacterial strategies.  
2.2.1.1 Non-Eluting/Static/Passive Antibacterial Strategies 
Static antimicrobial surface modifications are currently one of the most common coating 
strategies to target medical device related infections77. Such strategies are currently utilized in to 
develop coatings for catheters, infusion lines, vascular stents and grafts, and sutures to prevent 
biofilm formation and infection78. Many of the static antibacterial surface modifications 
employed to date act either by preventing initial microbial adhesion (anti-adhesive action), or, by 
killing microbes on contact with implant surfaces (contact-active action). 
Anti-Adhesive Surfaces 
Anti-adhesive or anti-fouling surface modifications passively target the initial adhesion of 
planktonic bacteria to the surface of implant materials. Due to their passive nature, these surface 
modifications are typically effective for long periods of time, leading to their popularity as 
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coatings for a variety of medical devices. In the clinic, most of these coatings are currently 
designed to be superhydrophobic to reduce bacterial adhesion and enable easy cleaning of 
various medical instruments79. Typically, the chemical composition and roughness of material 
surfaces are manipulated in conjunction to modify material wetting. In chemical modifications, 
low surface energy materials, such as fluorinated compounds, are utilized to increase 
hydrophobicity80. Once surfaces are hydrophobic, roughening in the micro and nano domain can 
increase the hydrophobicity of materials further in a process described by Wenzel81. For titanium 
materials, this process of roughening in conjunction with hydrophobic chemical treatments has 
shown effectiveness against clinically relevant pathogens in a variety of studies. Tang et al. was 
able to show a reduction in S. aureus colonization by roughening titanium surfaces with TiO2 
nanotubes, followed by surface functionalization with a fluoroalkyl silane82. Privett et al., 
through similar methods, was able to show the reduction in S. aureus and P. aeruginosa adhesion 
to roughened fluroalky silane coatings compared to untreated titanium surfaces83. This strategy, 
while abundant in work, has seen little clinical translation for titanium and other hard tissue 
implant materials. One reason for this lies in the differences between current commercial 
applications of these coatings and their hard tissue target area. 
Current applications of these coating technologies find greatest use as coatings for urinary 
catheters lines84–86. These devices have a placement period of under 30 days and are not intended 
to be integrated with host tissues, or, interface with protein-rich fluids such as blood and serum. 
For hard tissue implants, materials directly interface with protein-rich physiological fluids and 
nearly instantly develop a protein-rich conditioning film which dictates the foreign body 
response to the implant87. This conditioning film may contain a wide range of proteins such as: 
fibronectin, laminin, fibrin, collagen and immunoglobulins, which act as receptors to promote 
surface colonization88,89. Potential colonizers of the conditioning film include tissue cells and 
microorganisms which participate in a well established “race to (colonize)” the surface of the 
material43. Through the colonization of a strong monolayer of tissue cells, the implant surface 
can become resistant to colonization by microorganisms due to their viability, intact cell surface, 
and regular host defences87. In contrast, the colonization of the surface by adherent microbes 
leads to poor interactions with host tissue cells and potential implant failure. Anti-adhesive 
coatings that employ superhydrophobicity limit the binding of host proteins. This in turn inhibits 
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the adhesion of both bacterial and tissue cell adhesion, which leads to limitations for 
osteogenesis and implant fixation90.  
Given the importance of protein-tissue cell interactions for the successful fixation, integration 
and biofilm prevention, mild and more specific anti-fouling coatings are currently under 
investigation. Some of the most recent strategies in this area include pre-grafting specific ligands 
and proteins to titanium implant materials to yield selective anti-fouling properties. An et al. 
have shown that titanium implants materials grafted with bovine serum albumin (BSA) can 
provide reduced rates of infection by S. epidermidis in rabbit models91. While this study utilized 
albumin to specifically target the adhesion of host tissue cells, they did not directly assess its 
interactions with osteoblasts. In another study an anti-fouling grafted PEG brush coating was 
modified with the cell-adhesive arginine-glycine-aspartic acid (RGD) ligand to retain 
interactions with osteoblasts92. In this study, the coating provided a reduction in the adhesion of 
S. aureus to implant surfaces, while the RGD ligand-maintained interactions with osteoblasts. 
Dextran, commonly used to decrease thrombosis, has also been used as a specific anti-fouling 
coating material as it has been shown to provide specific tethering sites for bone stimulating 
proteins such as bone morphogenetic protein 2 (BMP-2). A study by Shi et al., illustrated that the 
adhesion of S. aureus and S. epidermidis can be reduced by 50% compared to control titanium 
substrates93.  
While mild and selective anti-fouling coatings have shown moderate success experimentally, 
lack of tissue culture and in vivo data limits the consensus that they possess the features required 
for bone implant usage. Other limitations include a lack of analysis relating to the fixation and 
stability of selective antifouling coatings89,94. Despite the lack of clinically relevant data, 
selective anti-adhesive surfaces present an interesting opportunity in the development of inert 
implant surfaces to reduce the risk of IAI.     
Contact-active Antimicrobial Surfaces 
Similarly to anti-fouling surfaces, contact-active surfaces have the potential to provide medical 
implants with antimicrobial properties without the release of biocidal agents. In contrast to anti-
fouling surfaces, contact-active coatings often contain immobilized biocidal agents which are 
designed to kill bacteria upon contact with implant surfaces. These immobilized biocidal agents 
include components such as: antibacterial elements, antibiotics, and anti-microbial polymers and 
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peptides. Most contact-active strategies currently employ some combination of these components 
which have shown promising results.  
The contact killing effects of antibacterial metallic elements has been known for hundreds of 
years. Oligodynamic effects, or the biocidal effect of metallic elements, were formally 
recognized in the late 19th century, although the usage of such techniques predates ancient 
times95. Although the antibacterial effects of antimicrobial elements are well established, their 
mode contact-killing action is widely debated. Until recently, their antibacterial action has been 
mainly attributed to the release of metallic ions from bulk materials as a method to penetrate cell 
membranes. This theory, however, has been proven to occur in conjunction with the direct 
antimicrobial action of contact with metallic elements, where sophisticated protocols were 
established to limit and monitor the release of metallic ions96,97. While the contact-killing action 
of antimicrobial elements has not been fully elucidated, they have shown success in providing an 
antibacterial effect in a variety of studies. Zeiger et al. showed that copper surfaces could be used 
to successfully inhibit the growth of E. coli in a contact-based system to mitigate nosocomial 
infections attribute to metallic devices98. More recently, Mauter et al. reported that grafting 
polyethyleneimine-coated silver nanoparticles to the surface of polysulfone membranes can 
provide excellent contact-active resistance to colonization of E. coli99. While metallic elements 
are most prevalent in this research area, recent work has also investigated the use of non-metallic 
antibacterial elements as well, such as selenium. Holinka et al. reported that selenium materials 
have potential as orthopedic implant coatings as they provided reduced attachment of S. aureus 
and S. epidermidis when compared to control titanium surfaces without affecting osteoblast 
viability100. 
Antibiotics and anti-microbial polymers and peptides function through damaging cell walls and 
inhibiting protein synthesis in microbes101. Most of these active components are designed to be 
contact-active through the use of polymeric spacers. These polymeric spacers are utilized to 
allow grafted antimicrobial components to penetrate the cell wall of an adhered bacteria (Figure 
2.5)102. Ketonis et al. utilized this strategy to covalently tether vancomycin to allograft bone 
which showed significant reduction in S. aureus related surface colonization and stability over 60 
days103. Given the emergence of antibiotic resistant strains of pathogens, such as methicillin 
resistant S. aureus (MRSA), antimicrobial polymers and peptides have become significantly 
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more popular as antimicrobial grafting agents. While antimicrobial polymers can be developed 
synthetically with processes such as amine quarternization, emphasis has been placed on natural 
antimicrobial polymers due to their inherent biocompatibility and decreased toxicity 
concerns104,105. Chitosan, known to possess natural antimicrobial properties, has been extensively 
studied as a natural polymer additive in contact-active antimicrobial systems. Chua et al. 
reported that coatings consisting of polyelectrolyte multilayers of hyaluronic acid and chitosan 
were significantly effective at reducing the adhesion of S. aureus on titanium implant 
materials106. Cao et al. developed a modified chitosan surface which introduced N-halamine 
structures that was effective at reducing the colonization of both S. aureus and E. coli compared 
to control surface films107. Work with grafting antibacterial peptides has been met with similar 
success. Kazemzadeh-Narbat at al. utilized a cationic antimicrobial peptide (AMP Tet213) in the 
development of an antimicrobial calcium phosphate titanium implant coating108. The developed 
coatings possessed antimicrobial activity against both Gram-positive S. aureus and Gram-
negative Pseudomonas aeruginosa while providing a non-cytotoxic surface for osteoblast-like 
cells. Similarly, Pfeufer et al, grafted a different cationic antimicrobial peptide (rHubD2) to 
titanium implant surfaces using self-assembled siloxane monolayers109. Coatings developed in 
this study possessed increased antibacterial efficacy against E. coli compared to titanium 
controls.  
 
Figure 2.5 Concept of contact-killing membrane-active biocides surface-coupled via a polymeric 
spacer. Adapted from Börner et al.102 
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While work on developing novel contact-active antimicrobial coating systems is emerging, there 
is still a high degree of skepticism with their possible translation as coatings for titanium implant 
materials. Similar to anti-adhesive coating systems, contact-active systems have shown little 
evidence of success in tissue culture and in vivo studies. This leads to a lack of conclusions 
related to the cytotoxicity, immunoreactivity, and genotoxicity of developed coatings in 
orthopedic and dental implant systems. In the case of contact-based coating solutions using 
antimicrobial elements, the release of toxic ions from coating matrices presents a relevant 
cytotoxic concern110–112. In the case of coatings based on grafting antimicrobial polymers and 
peptides, the sensitivity and robustness of covalent coupling over time presents another clinically 
relevant toxicity issue113. Finally, while repelling and killing microbes on contact are obviously 
advantageous in an antimicrobial system, they can be easily deactivated through their contact 
with physiological fluids. Non-specific fouling of these surfaces can occur from dead cells and 
other physiological contaminants which deactivates these antibacterial systems and can allow 
microbes to colonize. In these cases, only systems that employ the release of biocides can retain 
their activity. 
2.2.1.2 Elution-based/Active Antibacterial Strategies 
Elution-based antibacterial strategies rely on the release of biocidal components to form a 
bacterial inhibition zone around the implant surface. The formation of this inhibition zone, 
attributed to the flux of biocides from eluting coating materials, has been shown to both reduce 
surface colonization in vitro and prevent the formation of biofilms in vivo114. Additionally, the 
elution from coating materials at the site of implantation enables the delivery of high local doses 
of biocidal components without exceeding systemic toxicity levels115. Since dead microbial cells 
cannot actively adhere to the substrate, they typically do not cover and deactivate the releasing 
coating material at high densities. Eluting coating systems may contain a single or combination 
of biocides such as: antibiotics, silver compounds, quaternary ammonium compounds (QACs), 
and nitric oxide. Many elution-based antibacterial coating systems rely on either a diffusion-
controlled or a dissolution-controlled release method. These release methods can be further tuned 
to respond to certain biological cues, making the release of biocides stimuli responsive. Such 
triggered systems prevent the premature exhaustion of loaded biocidal components and mitigates 
the diminution of release the occurs in constant release systems102. In the area of antibacterial 
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coatings, each strategy affords different advantages and disadvantages in the localized delivery 
of biocides. 
Diffusion-Controlled Coating Systems 
Diffusion-controlled coating systems are non-erodible in physiological fluids and employ the 
delivery of biocides through reservoir or matrix delivery strategies. In a reservoir delivery 
system, biocides are dissolved or dispersed in a reservoir that is surrounded by a rate limiting, 
non-erodible membrane116. The release of biocides from the reservoirs of these systems are 
determined by their permeability and diffusion through a non-erodible membrane. In matrix 
delivery systems, biocides are dissolved or dispersed within the coating matrix without the 
presence of a rate controlling membrane. The release of biocides from these systems are 
determined by the concentration of biocide remaining within the permeable coating matrix. Both 
reservoir and matrix loading strategies have represented a large portion of work on antimicrobial 
implant coatings with a particular focus on the field of orthopedics.    
Using a reservoir-loading strategy, Vasilev et al. incorporated the antibiotic lefofloxacin between 
two non-erodible polymer layers117. They found that the release of lefofloxacin could be 
effectively controlled by modifying the thickness of the outermost polymer layer, leading to a 
reduction of S. aureus colonization on implant materials. Other reservoir delivery strategies have 
involved the loading of biocides within porous reservoirs followed by the application of a non-
erodible polymer coating membrane to control release. Michl et al. utilized this strategy to 
deliver nitric oxide from a porous reservoir in a controlled fashion to reduce the colonization of 
S. epidermidis on biomedical implant surfaces118. Kumeria et al., using a similar strategy, loaded 
titanium nanotubes with gentamicin and utilized a polylactic-co-glycolic acid film to control 
release119. Using this reservoir-release strategy the colonization of S. epidermidis was reduced 
while maintaining adequate osteoblast adhesion.  
The most common use of matrix-bound biocide delivery systems has been in the field of 
orthopedics. Here, the use of vancomycin and gentamicin imbedded within non-erodible 
poly(methyl methacrylate) (PMMA) cement beads and coating materials has become a standard 
feature of two-stage revisions50. The use of such materials has been shown to lower the rates of 
postoperative infections by 8-12% compared to the use of traditional systemic antibiotics120,121. 
More recent studies have investigated the use of similar delivery methods using different matrix 
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materials. Kumar and Munstedt used a non-erodible polyamide coating material loaded with 
silver to provide an effective release of silver ions, which prevented the colonization of E coli 
and S. Aureus on hard material surfaces122. Thatiparti et al., utilized a swelling cyclodextrin-
based coating matrix on titanium substrates to release vancomycin123. These coatings were able 
to inhibit the growth of S. aureus for over 28 days and retained osteoblast cytocompatibility.    
While diffusion-controlled systems have shown favourable results, there are significant 
limitations to their adoption as coating materials for orthopedic and dental implants. In non-
erodible coating systems, the matrix or release-limiting membrane is often a non-biodegradable 
polymer material. This poses questions as the long-term robustness and retention of these 
membrane and matrix materials as well as their ability to promote the colonization of healthy 
tissues. Additionally, the release of biocides in diffusion-controlled antibacterial coatings 
diminishes with time until the quantities delivered loose efficacy and become subinhibitory88. 
The release of subinhibitory concentrations of biocides over time not only limits the long-term 
effectiveness of these coating materials, but also leads to the development of biocide-resistant 
pathogens124.   
Dissolution-Controlled Coating Systems 
Similar to diffusion controlled antibacterial coating systems, dissolution-controlled systems 
enable the continuous release of imbedded biocidal components. In contrast to diffusion-
controlled systems, dissolution-based coating systems have release kinetics determined by the 
dissolution or erosion of their coating matrices in surrounding fluids. In these systems the release 
of imbedded biocides can be modified by changing the rate at which the coating matrix dissolves 
or erodes in the selected dissolution media. For this reason, the use of a variety of biodegradable 
organic and inorganic matrices have been explored as methods to develop antibacterial coatings 
that release biocides in the presence of physiological fluids. In the field of orthopedics, the 
controlled delivery of antibiotics based on these biodegradable or erodible coating matrices has 
become a popular area of research since the standardization of cementless prostheses125.  
Such systems have been developed using matrices composed of a variety of organic networks 
such as polylactic-co-glycolic acid copolymers (PLGA)126,127 and poly(D,L-lac- tide) 
(PDLLA)128–130 as well as inorganic networks derived from sol-gel precursors131,132. For 
example, Kim et al. utilized a biodegradable PLA coating network loaded with chlorhexidine to 
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improve the antibacterial efficacy of dental implant materials133. Through the degradation of the 
PLA coating network and release of chlorohexidine, the developed coating materials were able to 
effectively reduce the viability of S. aureus in culture. In a similar study, Metsemakers et al. 
developed a biodegradable PLGA coating matrix loaded with doxycycline to mitigate implant 
associate infection134. This coating material provided protection for titanium alloy implant 
materials against clinically relevant methicillin-resistant S. aureus (MRSA) in a rabbit model. As 
for inorganic systems, sol-gel materials show significant promise in their applications within 
orthopedic and prosthodontic domains. Typically composed of siloxane networks, developed sol-
gel films have notoriously high substrate adherence and possess natural osteoconductive 
dissolution products 135,136. In pioneering studies, Ducheyne et al. utilized this feature of siloxane 
networks to develop vancomycin loaded xerogel coatings to effectively inhibit the colonization 
of S. aureus on a variety of titanium implant materials131,137–139. Other sol-gel based coating 
networks have been loaded with silver compounds140–142, quaternary ammonium 
compounds143,144, and nitric oxide145,146 that have shown great robustness and effectiveness again 
clinically relevant pathogenic bacteria such as E. coli, S. aureus, S. Epidermidis, and S. mutans.  
While dissolution-based coating strategies certainly illustrate great potential for hard tissue 
implants, there are still some significant limitations to their adoption in the clinic. These erodible 
coating systems, especially those made of biodegradable polymers, have similar concerns related 
to their longevity and robustness within host tissues. Similar to diffusion-based systems, the 
release of biocides from the coating materials diminishes with time leads to the possibility of 
developing of biocide-resistant pathogens124. However, unlike diffusion-based systems the 
release kinetics associated with degradation in dissolution-based systems are often difficult to 
control, with some coatings only providing an initial burst release of biocides during the first few 
hours of contact with physiologic fluids89,124.   
Stimuli-Responsive Systems 
Materials that respond to external stimuli have been investigated in the biomedical field for 
decades with applications as biomedical sensors, actuators, and coating materials124. In the 
development of elution-based coatings, these systems can eliminate some of the major 
limitations to the designs of both diffusion and dissolution coating systems. Unlike the later 
systems which liberate and exhaust their imbedded biocides quickly and continuously, stimuli-
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responsive eluting coatings release imbedded biocides only in response to specific stimuli. 
Stimuli-responsive antibacterial coatings can rely on either the triggered degradation or swelling 
of the coating matrix to achieve controlled elution of imbedded biocides. The elution of biocides 
in both cases can be triggered by both physiological and exogenous stimuli.   
Most stimuli-responsive antibacterial coating systems rely on biological triggers from 
surrounding bacteria. Through their metabolic cycle, bacteria produce a range of acidic 
substances, such as lactic and acetic acid, which lead to a pH drop in their immediate 
environment147. For this reason, several antibacterial coating systems that respond to changes in 
pH have been investigated. Using a nano-valve reservoir equipped with a pH responsive 
membrane, Wang et al. successfully achieved the release of cinnamaldehyde and ampicillin in 
the presence of pathogenic bacteria148. These coating materials provided a trigger active defence 
against S. aureus, E. coli, and MRSA. In another study, Zhuk et al. combined cationic 
gentamicin, tobramycin and polymyxin B, with polyanionic tannic acid in the development of 
antibacterial polyelectrolyte multilayer films149. These films, responsive to changes in pH, 
strongly inhibited the growth of S. epidermidis and E. coli on surfaces and in surrounding media 
while maintaining osteoblast adhesion and viability. The pH change in the presence of bacteria 
can also be used to liberate grafted biocides in coating materials. Using this strategy, gentamicin 
was grafted to a PEO nanoparticle coating using pH-sensitive imine bonds150. Coated titanium 
materials showed selected release at lower pH ranges and inhibited the growth of S. aureus. 
While stimuli from bacteria are most often utilized to activate these systems, other biological 
triggers which result from infection can also be used. For example, in the case of wound 
infections, the on-site production of the enzyme thrombin increases dramatically151. Using this 
trigger, Tanihara et al. developed a coating material consisting of crosslinked PVA with a 
thrombin-degradable crosslinker152. This coating material effectively released gentamicin only in 
the presence of thrombin, which actively inhibited the growth of S. aureus and P. aeruginosa 
bacteria.  
Similar to biological stimuli, use of externally applied exogenous stimuli can afford a high 
degree of control over the release of biocidal components from stimuli-responsive coatings. 
Unlike biologically responsive coatings, exogenous stimuli can be applied in a prophylactic 
fashion, that may protect implant surfaces in the early stages of the “race to the surface” before 
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measurable chemical changes occur. Responsive coating materials can be triggered to release 
biocides from electrical, ultrasonic, photothermal, magnetic, and mechanical triggers153. For 
example, Esrafilzadeh et al. utilized an electropolymerized polypyrrole coating to allow the 
electrically controlled release of cipropfloxacin154. Coated conductive fibers were non-cytotoxic 
and displayed significant inhibition of both S. pyogenes and E. coli growth under electrical 
stimulus. In another system, Norris et al. developed a poly(2-hydroxyethyl methacrylate) 
hydrogel coating with ordered methylene chains as an ultrasound-responsive coating for 
indwelling protheses155. This system was able to retain loaded ciprofloxacin in the absence of 
ultrasound, and, provide controlled-release in the presence of low-intensity ultrasound. 
Triggered-release doses from this developed coating system provided significant inhibition to the 
growth of P. aeruginosa on material surfaces. Using a magnetic field, Aw et al. presented a 
coating system that can be used to release active drug components from a titanium nanotube 
reservoir upon application of magnetic stimulation156. In this work titanium implant materials 
equipped with titanium nanotubes were loaded with drug-encapsulated micelles and were 
released only under the presence of magnetic stimuli. While this work did not explicitly use the 
release of biocides or preform experiments with bacterial cultures, the encapsulation of 
antibiotics in such a system is promising in this area.  
While stimuli-responsive antibacterial systems provide “on-demand” therapeutic effects, there 
exist some limitations to their adoption in the clinic. For starters, there is a high degree of 
skepticism about how sensitive these systems are to their triggered stimuli in vivo. Given the 
dynamic nature of the body, systems that may promote release of biocides to changes in pH may 
not be suitably sensitive. Local pH changes associated the early stages of infection can be quite 
small are difficult to predict in vivo. Such pH changes can depend on the presence of different 
species of bacteria, the bacteria state (planktonic or biofilm) and the size and location of the 
implant. For this reason, many systems relying on release from biological stimuli may provide an 
effect too late as infections have been shown to occur as early as early as six hours of post-
operatively from small quantities of pathogenic bacteria114. For systems that rely on external 
stimuli to release biocides, their application may be limited as they require the pre-identification 
of infection before their application. For this reason, their applications may be inappropriate in 
conditions where there is a sudden onset of inflammation or viral attack. This strategy is also 
significantly limited by patient compliance and access to the clinic. 
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2.2.2 Osteoconductive Surfaces 
In the founding study by Brånemark, osseointegration was described as the direct anchorage of 
an implant material by the formation of bony tissue around the implant157. Since then, many 
alternative definitions have been proposed to better describe the details of this phenomenon. 
More recent definitions identify osseointegration as a foreign body response, one in which 
interfacial bone may be formed as a defence to shield surrounding tissues from implant 
materials158. Nevertheless, this integration originally identified by Brånemark remains a 
fundamental factor in promoting the bony attachment and fixation of hard tissue implant 
materials. A wonderful review by Albrektsson and Johansson breaks down the two major factors 
influencing osseointegration: osteoinduction and osteoconduction159.  
Osteoinduction describes the stimulation or promotion of undifferentiated pluripotent cells to 
differentiate into those within the bone-forming or pre-osteoblast cell lineage158. This process 
occurs naturally in bone fracture healing and implant incorporation. In a traditional healing 
process, sensitized surviving cells release local biochemical and biophysical cues that help 
promote the differentiation of pre-osteoblast cells160. BMP, a soluble bone growth factor known 
to be naturally released in response to bone trauma or remodeling, has been identified as one of 
the only known naturally inductive agents. Although the recruitment of pre-osteoblast cells is 
typically unobservable for several weeks, the process of osteoinduction begins immediately 
following implantation, making it a fundamental factor in the “race to the surface”. 
Osteoconduction describes the action of differentiated bone cells to promote bone tissue growth 
around foreign surfaces. This process includes the release of growth factors which serve as 
signaling agents for bone cells in the production of bony tissues. In many ways the process of 
osteoconduction depends on the process of osteoinduction. Unlike osteoinduction, 
osteoconduction is strongly dependent on the biomaterial used for implantation. For this reason, 
materials, topographical cues, and eluting agents are most frequently investigated to optimize 
osteoconduction since the injury at placement is often sufficient to recruit the differentiation of 
pluripotent cells.  
While initial osseointegration may be achieved through the strong osteoinductive and 
osteoconductive cues, the long-term stability and retained osseointegration remains a relevant 
issue. For this reason, surface strategies concerning the promotion tissue ingrowth and long-term 
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stability of hard tissue implants (osteoconduction and osseointegration) have been of primary 
focus of researchers. Many of such strategies promote these factors using topographical cues or 
bioactive coatings to ensure long term fixation of implant materials and prevent aseptic 
loosening. 
2.2.2.1 Topographical Strategies / Bioactive Topographies 
Surface topographies are important factors that influence the bioactivity of all biomaterials. 
Indeed, the effect of surface micro- and nanostructures are well established to determine cellular 
behaviors such as adhesion, proliferation and differentiation161. For this reason, altered 
topographies can influence osteoinduction, osteoconduction and, accordingly, improve 
osseointegration. To improve the bioactivity and osseointegration of titanium implant materials a 
variety of surface topographies have been developed that mimic the cellular microenvironment. 
Such surface strategies can be further separated into micro- and nanostructure templating which 
impart their own spatiotemporal cues to cells in vivo.  
Surfaces roughened in the micro-domain are used to promote osteoblast adhesion, differentiation 
and to provide an appropriate surface for the mineralization of extracellular matricies162. 
Through the addition of a micro-pattern to Ti6Al4V substates, Lu et al. was able to show 
increased apatite induction in vitro and increased bone growth and proliferation in vivo163. In 
another study, Liao et al. investigated the role of surface microtopography on bone cell 
differentiation164. Using a micro-pyramid design, they observed an increased differentiation of 
rat calvaria osteoblasts compared to smooth surfaces in vitro. Similarly, surfaces with nano-
topographies have been used to promote implant fixation. These structures are more similar 
natural physiological orientation of native bone and play an important role in bone cell adhesion 
and integration165. Many of the nanostructures developed on titanium surfaces are titania 
nanotubes due to their ease of tunability using traditional anodizing techniques166. Nune et al. 
used this strategy of anodizing Ti6Al4V to develop surface titania nanotubes with a pore size of 
~80 nm167. Their structures promoted the nucleation of apatite globules in vitro and improved the 
proliferation and adhesion of mouse pre-osteoblast cells in culture. In another study, Wang et al. 
developed titanium implants with 70 nm titania nanotubes168. Following a five-week 
implantation period in a pig model, nanotextured implant surfaces displayed increased bone-
implant contact and osseointegration compared to control titanium surfaces. Brammer et al., 
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using a smaller titania nanotube size (30 nm), also demonstrated increased osteoblast adhesion 
compared to control titanium surfaces in culture169.  
In general, topographical manipulation provides relatively simple and stable enhancement to the 
bioactivity of hard tissue implant surfaces. Addionally, the technologies to develop such 
topographies (anodizing, plasma spraying, acid-etching) are scalable, making them feasible as 
commercial solutions166. There are, however, major limitations to these strategies being used 
solely as implant surface materials. By developing surfaces that promote cell adhesion and 
proliferation, there is often an added increase to the adhesion and proliferation of microbes. 
Studies have shown that some nanotopographies, such as nanotublar and nanotextured titanium, 
while providing a favourable environment for osteoblasts, indeed increase the adhesion of 
microbes to implant surfaces170,171. For this reason, the implementation of such topographies may 
provide more of a risk to the success of intraosseous implants despite their promotion of 
osteoinductive and osteoconductive cues. Accordingly, other studies have investigated the use of 
such topographies in conjunction with bioactive coating materials to provide a more “cell 
tailored” surface.  
2.2.2.2 Bioactive Coatings 
While topographical roughening typically provides a non-specific influence on adhesion and 
proliferation, the effect of bioactive coating materials is often more specific to influencing bony 
ingrowth. Due to the release of naturally osteoconductive ions from these materials (such as Ca, 
P, Si, and Mg), they have the ability to stimulate osseointegration without providing factors to 
influence the adhesion or proliferation of microbes172. A wide range of such bioactive materials 
have been investigated for use as orthopedic and dental implants coatings. These include 
traditional calcium phosphate or hydroxyapatite coatings, bioactive glass coatings, and newly 
emerging bioactive hybrid coatings. 
Hydroxyapatite-based Coatings 
Calcium phosphates, and more specifically, hydroxyapatite (HA) coatings were among the first 
to be proposed to replace traditional cemented fixation of prothesis173. HA-based materials were 
identified as promising biomaterials due to their similar chemical and crystalline structure to the 
inorganic phase of human bone. The emergence of HA coatings in the clinic was further spurred 
by their early display of significant improvements to the fixation and lifetime of metallic 
27 
 
implants174. This has been identified to occur due the formation of a carbonated-HA layer on the 
surface of HA coated materials shortly after implantation in vivo. This structure results from the 
elution of calcium and phosphate ions from HA coating materials which induces the deposition 
of relevant physiological proteins and provides an appropriate scaffold for osteoblasts in the 
formation of new bony tissue174. Research in HA-based implant coatings spans decades and has 
been the study of many clinical trials175–178. For this reason, to date, HA-based plasma sprayed 
coatings remain the only orthopedic implant coating material approved by the FDA179.  
Despite thorough investigations into these materials, their clinical success and predictability 
remains controversial. Indeed, the integration of these materials in vivo compared to bare or 
textured titanium surfaces have been proven to be marginal, or in some cases, less effective180–
183. Such studies have helped to better elucidate the shortcomings of plasma sprayed HA-based 
coatings which include phase inconsistency, coverage and topographical concerns, and coating 
delamination. 
During the high temperature plasma spraying application of HA coatings to metallic substrates, 
HA can undergo phase changes, which in general, affect the crystallinity of the coating material. 
Such secondary phases include tricalcium phosphate, calcium oxide (CaO), tetracalcium 
phosphate (TTCP) along with amorphous calcium phosphate (ACP)184,185. Difficulties exist in 
consistently controlling these phases within the processing conditions of plasma spraying which 
can greatly affect the bioactivity (or lack thereof) of plasma sprayed HA-based coatings.  
Additionally, plasma spraying is a line-of-site technique which limits its ability to accommodate 
the fine contours or geometric complexities of some implant materials. This can lead to 
inconsistent coating thickness and heating of implant materials, affecting not only the phase of 
the coating material but also that of the metallic substrate179. Along with an inability to 
accommodate fine geometries, the coating application of HA-based materials are often quite 
thick and dense leading to the coatings inability to match the topography of pretreated surfaces. 
Such surfaces are unable to provide the relevant topographical cues attributed to substrate pre-
treatments (previously discussed) to improve the growth and proliferation of osteoblasts.   
Lastly, and perhaps most importantly, some studies have addressed the potential for HA-based 
coatings to undergo delamination in vivo174,186,187. As previously discussed, the delamination of 
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coating materials leads to the production of debris and micromotion of prosthesis, which can 
ultimately result in aseptic loosening.  
Other coating methods that utilize sol-gel liquid techniques have been developed to aid in the 
control of HA coating properties188. Despite their low temperature application, such coatings 
need to be cured at high temperatures to produce crystalline HA189,190. Through this calcination 
process secondary phases of HA are developed, which leads to inconsistent dissolution 
properties and, due to differences between the thermal expansion coefficients of the coating and 
substrate, often cracking. 
Although plasma sprayed HA-based coatings are the current standard and only FDA approved 
orthopedic and dental implant coating materials, there is a need for alternative materials that 
overcome their shortcomings. While the proposed bioactive conduction method through the 
release of osteoconductive ions remains a viable bioactive model, the lack of consistency in their 
material properties limit the application of these coatings in the clinic. Therefore, further studies 
have investigated coating materials with improved material properties while possessing similar 
osteoconductive strategies.  
Bioactive Glass Coatings 
Bioactive glasses consist of a variety of glass-ceramic materials (typically silicate based) that 
promote the bonding and mineralization of bone tissue. The first bioactive glass named 
“Bioglass” was invented by Larry Hench in 1969 and consisted of 46.1 mol.% SiO2, 24.4 mol.% 
Na2O, 26.9 mol.% CaO and 2.6 mol.% P2O5. The original Hench Bioglass has since been used in 
over a million patients in the repair of bone defects during oral and orthopedic surgeries191,192. 
Such glasses can be synthesized using a traditional melt-quench methods or sol-gel techniques. 
Sol-gel derived bioactive glasses display higher surface areas, rates of bioactive ion release, HA 
formation and crystallinity compared to melt-derived glasses, and have thus been more 
frequently studied193. Almost all synthesized bioactive glass materials contain Si and Ca species 
as these ions in specific concentrations are known to elicit positive bioactive responses such as 
the promotion of new bone tissue growth191. An excellent review by Jones delves in great detail 
into various bioactive glass compositions and their uses as bone-growth grafting materials192. As 
Jones highlights in his review, despite their ability to promote rapid bone growth, these materials 
pose some complications for applications as implant coatings.  
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Most feasible bioactive glass coatings are synthesized using the sol-gel technique. Sol-gel 
systems, briefly touched on in Chapter 2.2.1.2.2, are prepared through the hydrolysis and 
condensation of liquid ceramic precursors. Since sol-gel materials typically have higher surface 
areas and porosities compared to traditional melt-quench glasses, they often better promote cell 
adhesion and tissue ingrowth as coatings194. Using a sol-gel synthesis, Köseoglu et al. developed 
a HA and bioactive glass dual coating for use on metallic implants195. Their HA/bioactive glass 
coating material displayed significantly more apatite deposition during in vitro testing than HA 
coating materials. In another study, Hamadouche et al. used a sol-gel derived Bioglass 
formulation to coat alumina implants196. These coatings increased the deposition of HA on 
implant surfaces in vitro and eliminated aluminum leaching compared to uncoated controls. Both 
of these coatings, however required the use of high curing temperatures (>600°C) to enable the 
inclusion of calcium into the coating network. This led to significant cracking and fissures of the 
inorganic coating materials, leaving in question their robustness and longevity of these coatings 
in vivo.  
When form is of no concern, such in the case of powder development, processing bioactive 
glasses at high temperatures remains ideal from a processing perspective. For materials that 
assume the form of a mold or template, as in the case with scaffolds and coatings, developed 
materials are often too brittle to provide adequate support, or, crack and delaminate upon curing 
on metallic substrates. For implant coatings, this leads to many of the same issues associated 
with the sol-gel processing of HA-based materials, also prone to material separation and 
significant coating cracking. The reason for such cracking can be attributed to the large 
shrinkage that occurs during drying and the evaporation of the liquid by-products of the sol-gel 
synthesis192. Unlike HA-processing where crystallinity is the main objective, high temperatures 
for bioactive glass processing are used to ensure that all liquid components are included into the 
coating network. For example, it is common for bioactive glasses to include Ca into the coating 
network using sols containing CaNO3 or CaCl2
197. For Ca to be included into the cured network 
and to remove the potentially toxic salt by-products, these materials must be annealed at >400°C. 
This process is not always ideal, and often, due to the salts solubility in the pore liquor of the sol, 
can lead to an inhomogeneous surfaces distribution of elements198. 
. 
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Hybrid Material Coatings 
To improve upon the mechanical properties and processability of bioactive glasses for use as 
coatings, several composite and hybrid systems have been developed to combine organic 
polymers with sol-gel ceramic materials. Through the simple blending of these organic and 
inorganic networks, sol-gel composite materials can be developed. This method, however, 
usually leads to inhomogeneous materials with mismatching degradation rates, which can cause 
instability and premature deterioration of composite materials 192,199. Alternatively, hybrid 
material systems, possessing nanoscale molecular interactions between the organic and inorganic 
phases, have shown significant improvements in stability over their composite counterparts. 
These hybrid materials are further characterized based on the molecular interactions between 
their organic and inorganic components. When weak molecular interactions (such as hydrogen 
and van der Waals bonding) are present between organic and inorganic components they are 
designated as class I hybrids. In the case where strong covalent interactions are present between 
both organic and inorganic components materials are deemed as class II hybrids. Highlighted 
below are examples of promising class I and class II hybrid materials for use as implant coatings 
as well as a discussion on integration of calcium. 
Using class I hybrid materials, a variety of researchers have been able to improve the bioactivity 
of implant surfaces.  For example, Catauro et al. has investigated the use of poly (ɛ-caprolactone) 
(PCL) and polyethylene glycol (PEG) to develop class I siloxane hybrid coatings200–202. These 
coatings, when applied to Ti substrates, displayed superior bioactivity by promoting the vitality 
of mouse embryonic fibroblast cells compared to bare Ti substrates while displaying crack-free 
coatings with good adhesion properties. Other studies have investigated using natural polymers 
such as chitosan and gelatin as the organic components in their class I hybrids. Pebdeni et al. 
developed a nanofiber coating for use on orthopedic implants that consisted of chitosan, PEO, 
and silica203. Chitosan, in this study, acted to improve the flexibility of the developed nanofibers 
and increase the attachment and growth of fibroblasts. In another study, Jun et al. used chitosan 
to improve the material properties of a bioactive sol-gel coating composed of 
tetramethylorthosilane (TMOS), CaCl2 and triethyl phosphate
204.  Hybrid coating materials were 
crack-free compared to their inorganic counterparts and displayed appropriate levels of cell 
attachment, bone forming ability, and mineralization.  
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Compared to the simple entanglement of organic and inorganic chains, class II hybrids act as 
single-phase materials exhibiting improved mechanical properties and material homogeneity 
compared to class I hybrids. This is particularly the case with dissolution characteristics of 
hybrid materials. Due to the lack of covalent coupling present between the two phases in class I 
hybrids, organic components can often be lost more rapidly than inorganic components in 
dissolution studies. This emphasizes the fact that class II hybrids may be more suitable for 
implant coatings where material properties, including degradation and dissolution rates, are often 
congruent throughout the material. 
Class II hybrid materials has become an increasingly popular research area in the development of 
hard tissue implant coatings. Studies have investigated the use of a variety of organic, coupling, 
and inorganic agents in the development of these coatings. Many relevant studies have 
investigated class II systems consisting of chitosan as an organic component, coupled to 
inorganic siloxane networks using 3-glycydoxytrimethoxysilane (GPTMS). For example, Palla-
Rubio et al. used such a system as a coating for Ti implant materials that facilitated the release of 
osteoconductive Si which promoted the proliferation of human fibroblasts in culture205. In other 
studies, Shirosaki et al. showed how these coating materials could also promote the adhesion and 
proliferation of an osteoblastic cell line (MG63) compared to relevant controls and remain stable 
for up to 6 months in enzymatic solutions206,207. Other materials have been developed using 
similar systems but with varying organic networks components such as gelatin, poly(γ-glutamic 
acid), and PEG208–210. 
These materials, owed to their low temperature processing, have also been able to manifest 
antimicrobial properties. For example, the coating materials involving chitosan above were able 
to provide a degree of antimicrobial efficacy against relevant pathogenic bacteria while 
providing a crack-free surface204,205. Other examples include the work of Pebdeni et al. and 
Hernández-Escolano et al. where they used the low temperature synthesis of the hybrid coating 
materials to enable the loading of temperature-sensitive antimicrobial agents cefepime and 
procaine, respectively203,211. These materials provided a significant antimicrobial effect along 
with displayed signs of bioactivity. The multifunctional nature of these materials has become 
particularly attractive to researchers as coatings that can promote osseointegration whilst 
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mitigating microbial proliferation can effectively eliminate both major failure modes effecting 
implantology today.  
Most of the above-mentioned class II hybrid materials, and those reported in literature, consist of 
a polymer-siloxane system. The synthesis and integration of calcium into such materials remains 
challenging due to their low temperature synthesis and curing temperatures192. For this reason, 
more recently, calcium alkoxides have been investigated as precursors to incorporate calcium 
into the inorganic portion of sol-gel hybrid materials. These precursors participate in the same 
network forming hydrolysis and condensation reactions as traditional silica precursors, allowing 
their simple integration into these networks at room temperature 
Accordingly, more advanced methods in the development of multifunctional hybrid coatings 
have utilized calcium alkoxides to allow low temperature Ca integration into sol-gel networks. 
For example, Li et al. developed PEG/SiO2-CaO class II hybrid coating materials using calcium 
methoxyethoxide (CME)212. Hybrid materials developed in this study possessed a degradation-
controlled release of calcium and promoted apatite deposition on all material monoliths  Coating 
materials were able to be cured at low temperatures and displayed enhanced apatite deposition 
while exhibiting good cell viability and proliferation.  In another study, Poologasundarampillai et 
al. developed Poly(γ-glutamic acid)/SiO2-CaO hybrids using the same CME precursor213. Most 
of the calcium alkoxides used to date, however, have had a high sensitivity towards hydrolysis 
and condensation reactions in the presence of water. This instability in aqueous systems often 
leads to premature gelation of the inorganic network leading to poor and inhomogeneous 
integration of calcium into hybrid materials. Additionally, many of these calcium alkoxides, if 
not hydrolyzed completely, can leach toxic by-products in vivo (such as methanol for calcium 
methoxide and calcium methoxyethoxide).  
Therefore, while bioactive class II hybrid materials present desirable characteristics, there is a 
need to improve their properties for use as hard tissue implant coatings. In an effort to better 
assess their potential to be clinically translatable, more rigorous delamination initiatives should 
be pursued to assess the adhesive properties of these coatings. Additionally, due to their low 
temperature synthesis, antimicrobial agents should be opportunistically added to material 
coatings to provide implant materials with an effective resistance against pathogenic bacteria. 
And lastly, there is a need to investigate new calcium alkoxide precursors that possesses less 
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toxic degradation products and increased resistance to water to enable the inclusion of calcium 
into coating networks at low temperatures. The above points will be the focus of the work 
presented in this thesis.  
2.3 Rationale of the Study 
Titanium implant materials, while ideal from a biomechanical standpoint, are plagued clinically 
by two major complications: IAI and aseptic loosening. While these issues seem distinct given 
their nomenclature, their interrelation and the “race to the surface” between native cells and 
pathogens is often attributed to the success or failure of implants in both domains43. Various 
antimicrobial coating strategies have been developed to target a range of pathogenic bacteria 
which each afford their own advantages and disadvantages. Osteoconduction on the other hand, 
has been well established to be promoted by topographical stimuli and the dissolution of relevant 
inorganic ceramic materials. Both coating strategies, in addition to their relevant cues, need to be 
resistant fracture and delamination to be feasibly implemented in the clinic.  
Therefore, the purpose of this study is to develop multifunctional coating materials that can: 
1. Manifest antimicrobial properties that can be applied in a complementary manner 
(contact and release based) 
2. Provide inherently osteoconductive/bioactive physiological cues 
a. Through the use of hybrid bioactive glass networks 
b. Using a new calcium alkoxide precursor 
3. Possess a degree of mechanical robustness to promote clinical translatability 
 With this in mind, this study describes the synthesis of robust class II hybrid multifunctional 
coatings to improve success of titanium implant materials. 
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Chapter 3: Development of robust chitosan–silica class II hybrid coatings 
with antimicrobial properties for titanium implants* 
3.1 Introduction 
Titanium and its alloys have been the material of choice for biomedical implants over the past 
half century. Their low specific weight, high strength to weight ratio and resistance to corrosion 
are features that make titanium the ideal bulk material for numerous clinical applications1. These 
include orthopedic and dental implants where their resistance to chipping and capacity to endure 
repetitive high loading conditions are an advantage over non-metallic substrates. Furthermore, 
the titanium dioxide layer that forms on their surfaces is highly inert and biocompatible to the 
cells and extracellular matrix of surrounding tissues. 
However, the bio-inertia of titanium surfaces is accompanied by a lack of any significant 
antimicrobial properties. While implanted titanium materials are well received by the osseous 
and connective tissues of their host, microbial contamination of their surfaces and the surgical 
site can often lead to sustained infections and unfavorable patient outcomes. These implant-
associated infections are currently a major cause of orthopedic and dental implant failures. Post-
operative infections associated with biomaterial implantation range from 2%–5% for orthopedic 
procedures and 4%–11.5% for dental and oral surgeries2–4. These infections are often extremely 
resistant to systemic antibiotics and persist until the implant has been surgically retrieved. 
The persistence of implant-associated infections is likely due to the presence of polymicrobial 
biofilms that have formed on implant surfaces. These biofilms contain bacteria that are encased 
within a bacterial-excreted polysaccharide matrix, which is highly adherent to biomaterial 
surfaces and largely resistant to the external environment. Accordingly, the bacteria within 
biofilms may be up to 1000 times more resistant to antibiotics than bacteria that are suspended in 
a planktonic state3,5. 
Therefore, research has now been directed toward the modification of implant surfaces to prevent 
initial bacterial adhesion and subsequent biofilm formation. Most antimicrobial strategies have 
relied on either static antimicrobial activity from direct or indirect surface modifications or they 
 
* A version of this chapter has been published: Z. Gouveia, H. Perinpanayagam, J. Zhu, Coatings 2020, 10, 1–20 
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have implemented release-based antimicrobial action using biocides imbedded within material 
surfaces. 
Static antimicrobial strategies involve modifications to implant surface properties which can alter 
their surface roughness, hydrophilicity and/or surface functional groups6–8. Therefore, such 
intensive surface modifications can lack selectivity for biomedical applications and may 
inadvertently reduce favorable surface interactions with mammalian cells. These cellular 
responses are necessary for cell attachment and adequate osseointegration with surrounding 
tissues9. Furthermore, while static antimicrobial factors may inhibit or retard initial bacterial 
adhesion and proliferation, they become ineffective once biofilms become established on 
biomaterial surfaces. 
In contrast, release-based antimicrobial strategies typically employ a coating system that enables 
the release of biocidal components such as antibiotics, cationic molecules or metallic 
compounds10–13. Systems that employ release-based antimicrobial strategies often involve an 
initial burst release of the imbedded biocidal agents that have short-term effects, which are 
followed by a subsequent diminution of activity. Additionally, for release-based systems the 
choice of an antibiotic as a biocidal agent may be contraindicated by the rise in antibiotic-
resistant infections from resistant bacterial strains14. 
Therefore, recent interest has focused on the utilization of metallic nanoparticles as antimicrobial 
agents, due to their broad-spectrum effects15,16. Among these, silver nanoparticles (AgNPs) have 
garnered significant interest due to their limited cytotoxicity, ease of synthesis, low minimum 
inhibitory concentrations for many pathogenic bacteria and their antimicrobial efficacies in both 
static and release-based applications17–19. AgNPs provide antibacterial efficacy through both the 
release of silver ions (Ag+) and through the direct action of metallic AgNPs (Ag0). The Ag+ 
provide antibacterial effects by permeating cell walls, damaging proteins and membranes and 
causing oxidative stress20. The antibacterial action of Ag0 is by a similar permeation-based 
toxicity, as well as through cell surface attachment and disturbances to the permeability and 
metabolism of bacterial cells21,22. 
Currently, surface modifications to titanium implants are limited commercially to surface 
treatments (physical roughening, anodizing, chemical etching, etc.) and inorganic ceramic 
coatings that typically incorporate hydroxyapatite (HA) as a bioactive layer. However, the 
51 
 
application of such ceramic coatings has numerous disadvantages such as slow processing 
(biomimetism), high temperature application (plasma spraying) and overly thick or brittle film 
deposition, which limit their ability to be loaded with process sensitive antimicrobials 23–25. 
Therefore, there was significant interest in using alternative coating materials containing organic 
components, which could improve the material properties and processability of coating materials 
while retaining an adequate level of bioactivity within tissues. 
One organic material being considered for coating applications is chitosan, which is a naturally 
occurring polycationic polymer derived from the shells of crustaceans. Chitosan is both 
biocompatible, biodegradable and has antibacterial effects. Due to these unique properties, 
chitosan has already found use in multiple biomedical applications that include drug delivery26–
28, tissue engineering29–31, ophthalmology32–34 and as medical device coatings35–37. However, 
chitosan alone has a propensity to degrade and has weak mechanical properties in vivo that 
would make it a poor choice as a coating for implantable titanium materials. 
Therefore, the development of class II organic–inorganic hybrid materials that retain the biologic 
benefits of polymers such as chitosan, while enhancing their physical properties, has been 
proposed38–40. By covalently coupling biopolymers to inorganic precursors, hybrid materials 
could be developed that retain their biocompatibility and have improved mechanical properties. 
For example, gelatin has been utilized as the organic component in a class II hybrid framework 
with silica, to develop highly porous scaffolds for bony tissue applications with tunable 
mechanical and dissolution properties41. Similarly, chitosan has been shown to be an appropriate 
biopolymer for covalent coupling with silica networks that are otherwise too brittle42–45. 
Coupling with inorganic silica networks, in these cases, significantly improves the mechanical 
properties of chitosan alone for applications as biomaterials. Similar studies have used chitosan 
as a primary organic network modifier and sole antimicrobial agent in the development of 
coatings for titanium implant materials46,47. These studies have shown that such materials could 
promote bone forming ability and provide an antimicrobial effect against clinically relevant 
pathogens. This study evaluated the robustness of these materials and investigated the inclusion 
of AgNPs into the coating network to improve antimicrobial efficacy against both static and 
planktonic pathogens. 
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Therefore, the purpose of this research was to develop robust and functional chitosan–silica 
coatings for titanium implants. The objective was to develop robust chitosan–silica class II 
hybrid coatings that could be loaded with AgNPs for manifest antibacterial properties. 
3.2 Materials and Methods 
3.2.1 Synthesis of Coating Materials 
All chemicals involved in the preparation of coating materials were purchased as laboratory 
grade reagents from Sigma Aldrich (St. Louis, MO, USA), unless otherwise specified. There 
were four formulations of chitosan–silica hybrid coating materials prepared (Table 1). Their 
composition and preparation were identical, except for their organic content that varied from 
20% to 80% by weight. The variation in organic content was achieved by modifying the ratio of 
tetraethoxysilane (TEOS) to chitosan coupled with 3-glycidyloxypropyltrimethoxysilane (Ch-
GPTMS). 
 
Table 3.1 Composition of hybrid coatings. 
Components 
80% Organic Blends 60% Organic Blends 40% Organic Blends 20% Organic Blends 
80ChSi 80 ChSi-nAg 60ChSi 60ChSi-nAg 40ChSi 40ChSi-nAg 20 ChSi 20 ChSi-nAg 
Ch-GPTMS a 80 80 60 60 40 40 20 20 
TEOS b 20 20 40 40 60 60 80 80 
AgNPs c – 0.023 – 0.023 – 0.023 – 0.023 
a Chitosan coupled with 3-glycidyloxypropyltrimethoxysilane (network wt.%); b tetraethoxysilane (network 
wt.%); c silver nanoparticles (total coating wt.%) 
 
A coupling reaction between chitosan and GPTMS was initiated as previously described42,45. 
Briefly, chitosan (200 kDa, 82% DDA) was dissolved in an acidic solution (HCl, pH 4.0) to a 
concentration of 18 mg/mL. This chitosan solution was strained through a cotton filter and then 
GPTMS was added at a 1:1 molar ratio of solubilized chitosan to GPTMS and left to couple over 
a period of 24 hours at room temperature. Following coupling, an appropriate amount of 
hydrolyzed TEOS (pH 4.0) was added to the Ch-GPTMS solution to yield hybrids of varying 
organic content (20, 40, 60 and 80 wt.%). The inorganic component of the hybrid material was 
controlled independently using TEOS. After the addition of an appropriate amount of TEOS as 
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the inorganic component in the hybrid material, duplicate preparations of each coating material 
were loaded with AgNPs (0.023 wt.%) and agitated maximally for 1 h. 
The AgNPs were synthesized by a chemical reduction method, as previously described48–50. 
Initially, a solution of NaBH4 (2.0 × 10
–3 M) was prepared in double distilled water and chilled 
in an ice bath for 15 min. Concurrently, a solution of AgNO3 (2.0 × 10
–3 M) was prepared in 
double distilled water. While the solution of NaBH4 was stirred vigorously, the solution of 
AgNO3 was added dropwise with NaBH4 being in excess (NaBH4:AgNO3 6:1 v/v). Following the 
addition of AgNO3, stirring was stopped and the AgNP colloid was stabilized with an 
appropriate amount of polyvinylpyrrolidone (0.3 wt.% PVP) solution. The PVP stabilized AgNP 
solutions were then subjected to repeated cycles of ultracentrifugation and freeze-drying to 
collect concentrated AgNPs. 
The synthesized AgNPs were examined by transmission electron microscopy (TEM). Nickel 
grids (400 mesh) were dipped in aqueous suspensions of AgNPs and allowed to air-dry. Analysis 
was performed using a Philips 420 TEM at an accelerating voltage of 80 kV equipped with an 
AMT 4000 digital imaging system. 
3.2.2 Deposition of Hybrid Coatings 
Commercially available titanium alloy (Ti6Al4V) discs (9 × 9 × 2 mm) were polished with 
silicon carbide study up to 1200 grit, then rinsed with acetone and washed by ultrasonication in 
deionized water. Some discs were then immersed in a solution of HCl and H2SO4 in double 
distilled water (2:2:1 v/v) at 65 °C for 20 min. Following this etching process, these discs were 
neutralized with a NaHCO3 solution (0.5 M), washed by ultrasonication in deionized water and 
ethanol and dried at 40 °C. 
The polished and acid-etched Ti6Al4V discs were used as substrates for the application of 
chitosan–silica class II hybrid coatings in a standard dip-coating protocol51. Briefly, the discs 
were immersed in freshly prepared chitosan–silica sol using a dip and withdrawal speed of 100 
mm/min. Following dip coating, the discs were dried in a vacuum oven at 80 °C for 3 h and then 
stored at room temperature. 
54 
 
3.2.3 Characterization of Coating Surfaces 
The hybrid coating surfaces were carefully analyzed for their chemical structure, composition 
and microtopographies. The presence of covalent coupling between chitosan and GPTMS was 
identified by solid–state nuclear magnetic resonance (NMR). 13C Magic-angle spinning (MAS) 
NMR spectra were acquired at natural abundance on a 14.1 T Inova I600 NMR Spectrometer 
(Varian Inc., Palo Alto, CA, USA) operating at 79.4 MHz. Hybrid coating samples were spun at 
13 kHz using a 3.2 mm MAS HXY probe. In addition, the degree of covalent coupling was 
measured with a ninhydrin assay as follows52,53. Briefly, a ninhydrin solution was added to solid 
suspensions of the coating samples at 80 °C for 20 min. Solid suspensions were prepared by 
grinding dried coating materials with a mortar and pestle and suspending the fine powder in 
double distilled water. The absorbance of prepared suspensions was measured at 570 nm using a 
spectrophotometer (G1103A, Agilent Technologies, Santa Barbara, CA, USA) and compared to 
a standard curve prepared from the chitosan batch used in this study. Using the standard curve, 
the percentage of free (uncoupled) amino groups present in the coating samples was calculated. 
The surface morphologies and microtopographies of the hybrid coatings were examined by 
scanning electron microscopy (SEM), using a Hitachi SU8230 Regulus Ultra High-Resolution 
Field Emission SEM (Hitachi, Tokyo, Japan). The coated Ti6Al4V discs were secured to metal 
stubs with carbon tape and sputter coated with 10 nm gold nanoparticles prior to analysis. 
Additionally, elemental distribution maps of the coating surfaces were obtained by energy-
dispersive X-ray spectroscopy (EDX) using a Bruker X-Flash FQ5060 Annular Quad EDX 
detector (Brunker, Billerica, MA, USA). 
The chemical structure of the coatings and the presence of key functional groups were analyzed 
using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR). Hybrid 
coating samples were analyzed using a Bruker Tensor II system with a Platinum ATR (unit 
A225) equipped with a 2 × 2 mm diamond crystal (Brunker, Billerica, MA, USA). Spectra were 
acquired in the range of 4000–400 cm−1, at a resolution of 4 cm−1 and taken as an average of 32 
scans. All spectra were analyzed using OPUS spectroscopy software. 
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3.2.4 Evaluation of Mechanical Properties 
The mechanical properties of the hybrid coatings and their interface with underlying titanium 
substrates were carefully evaluated. Their surface energies were analyzed by measuring the 
water contact angle for double distilled water. The water contact angles were measured by the 
DataPhysics OCA 30 (DataPhysics, Filderstadt, Germany) using the sessile drop method. Drop 
volume was maintained at 10 µL and replicate (n = 5) measurements were obtained. 
Overall, adhesion of the hybrid coatings to their titanium substrates was evaluated qualitatively 
using an abbreviated cross hatch adhesion protocol (ASTM D335954). Briefly, the coatings were 
scored using a cross hatch cutter (Elcometer, Manchester, United Kingdom) with standardized 
blade spacing (11 × 1 mm). There were two perpendicular cuts (20 mm) that were made with a 
steady motion and force to penetrate the coating layer and create a lattice pattern. ASTM 
standard tape was then placed over the center of the grid, smoothened with a pencil eraser and 
then withdrawn in a steady motion at an angle of 180° from the substrate. Resultant defects in 
the coating layer were examined using a brightfield microscope at a magnification of 50× 
(Mitutoyo, Kanagawa, Japan). 
Quantitative assessments of the coatings’ adhesion to titanium substrates and risks of 
delamination were obtained through a tensile adhesion protocol as follows (Figure 3.1)55. The 
coated Ti6Al4V discs were fixed to aluminum dolly specimens with T-88 epoxy resin (System 
Three Resins, Inc., Lacey, WA, USA). The affixed samples were secured to a tension adapter in 
an Adelaide TCC universal testing machine (Adelaide Testing Machines, Toronto, ON, Canada), 
and forced apart at a speed of 3 mm/min. Each coating and treated titanium substrate were tested 
in triplicate (n = 3). Following separation, the site of delamination was carefully examined, with 
the coating adhesive strength calculated as: 
Adhesive Stength (MPa) =
Load at Failure (N)
Coated Area (m2)
 (1) 
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Figure 3.1 Adhesive tensile testing of hybrid coatings on titanium (Ti6Al4V) substrates. The 
coating (black line) and Ti6Al4V substrate (red line) are forced apart (yellow arrows) in 
an Adelaide TCC universal testing machine 
3.2.5 Evaluation of Antimicrobial Properties 
The antimicrobial properties of the hybrid coatings were evaluated against common Gram-
positive and -negative bacterial pathogens. Their antimicrobial efficacies were assessed 
quantitatively against Escherichia coli (Gram-negative, ATCC® 25922) and Staphylococcus 
aureus (Gram-positive, ATCC® 25923) suspended in planktonic bacterial cultures and on their 
formation of adherent biofilms. Separate E. coli and S. aureus monocultures suspended in Luria 
Bertani (LB) medium were prepared from inoculum. 
The coated discs were disinfected and sterilized in preparation for bacterial cultures. They were 
rinsed twice with ethanol (70% v/v), washed thrice with phosphate buffered saline (PBS), then 
placed in a tissue culture hood and exposed to UV light for 30 minutes to ensure sterility. 
Replicate coated discs (n = 3/coating) were submerged in each bacterial suspension of 105 
CFU/mL and incubated at 37 °C under aerobic conditions. At predetermined times (1, 2, 4, …, 
24 h), samples of the bacterial suspension were withdrawn and their absorbance (OD600) 
measured using a spectrophotometer (Agilent Technologies, Santa Barbara, CA, USA). Viable 
cells from the samples of bacterial suspension were counted by serial dilution and the spread 
plate method using 100 × 15 mm LB Agar plates. 
Additional sterile coated discs (n = 3/coating) were submerged in each bacterial suspension of 
105 CFU/mL and incubated at 37 °C under aerobic conditions for a period of 24 h. Following 
incubation, the coated discs were gently rinsed thrice with sterile PBS, transferred to sterile 
culture tubes containing 2 mL of fresh LB medium and subjected to ultrasonication for 5 min. 
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Viable bacteria were harvested from the sonicated samples and counted by serial dilution and the 
spread plate method using 100 × 15 mm LB Agar plates. The inhibition of bacterial biofilm 
formation was calculated with CFUcontrol representing colonies on uncoated control (Ti6Al4V) 
surfaces and CFUcoating being the colonies on each coating as: 
 
Bacterial Inhibition (%) =
CFUContol − CFUCoating
CFUControl
× 100 (2) 
  
3.2.6 Statistical Analysis 
The data in this study were analyzed using GraphPad Prism software (V 6.01). All data are 
expressed as mean ± standard deviation. One-way ANOVA analyses were used to make 
comparisons among multiple groups. Group differences were specified using Tukey’s post hoc 
tests with the differences considered statistically significant when p < 0.05. 
3.3 Results and Discussion 
3.3.1 Characterization of Coating Materials 
The first step in this research was to successfully synthesize class II hybrid coating materials. 
Class II hybrids have been shown to display synergistic properties that complement the 
advantages of both organic and inorganic polymers56. In this study, class II hybrid materials were 
developed using chitosan as an organic polymer component, GPTMS as a silane coupling agent 
and TEOS as an independent inorganic network agent. Initially, covalent coupling occurred 
between the epoxide functional group of GPTMS and the primary amine group of chitosan 
(Figure 3.2(A)). Concurrently, the acidic conditions of the reaction catalyzed the hydrolysis of 
ethoxysilane bonds to form Si–OH pendants. Following coupling, pre-hydrolyzed TEOS was 
added to the solution of functionalized chitosan, and polycondensation of the network proceeded 
to occur through the formation of Si–O–Si linkages. After the addition of hydrolyzed TEOS, 
some of the materials had aqueous suspensions of AgNPs added to their blend to create 
antimicrobial coatings. 
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Figure 3.2 Chemical synthesis of chitosan–silica Class II hybrids and imbedding of silver 
nanoparticles (AgNPs). (A) Coupling of chitosan and 3-
glycidyloxypropyltrimethoxysilane (GPTMS) in mildly acidic conditions; (B) 
polycondensation of coupled chitosan and hydrolyzed tetraethoxysilane (TEOS); (C) 
imbedding AgNPs into the hybrid sol network. 
 
To verify that these coating materials were indeed class II hybrids, it was essential to confirm 
that there was covalent coupling between the organic and inorganic components. In this study, 
the coupling of chitosan using its primary amine functionality to GPTMS was evaluated, because 
the epoxide functional group of GPTMS is known to form covalent bonds with nucleophilic 
functional groups such as amines under acidic conditions57. To observe these reactions between 
GPTMS and chitosan, 13C MAS-NMR spectroscopy was used. The coupling reaction could be 
followed by identifying the peak assignments previously described (Figure 3.3)43. The 13C 
resonance labeled ‘6’ (associated with the carbon in the epoxide ring) at δ ~47 ppm, showed that 
some of the epoxide rings of GPTMS had been opened by a nucleophilic attack of the primary 
amine of chitosan to form a secondary amine. There were no other reactions between chitosan 
and GPTMS identified, which indicated that the coupling occurred exclusively between the 
primary amine of chitosan and the epoxide of GPTMS. Indeed, these findings are consistent with 
what has been reported by others for the coupling of chitosan and GPTMS under similar 
conditions43,45. 
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Figure 3.3 Characterization of covalent coupling in hybrid materials. 13C Magic-angle spinning 
nuclear magnetic resonance (MAS-NMR) spectra of the hybrid material. Covalent 
coupling was confirmed by peak “6”, which was from a nucleophilic attack of the 
primary amine in chitosan on the epoxide of 3-glycidyloxypropyltrimethoxysilane 
(GPTMS). The absence of other peaks associated with coupling of these species indicated 
that the amine in chitosan was the sole site of coupling. 
 
As a method to conveniently measure the degree of covalent coupling between chitosan and 
GPTMS, a ninhydrin assay was utilized (Figure 3.4). This assay enabled the detection of primary 
amine groups that may have remained uncoupled during the development of the hybrid materials. 
Through this colorimetric assay, the transformation of primary amines in the deacetylated units 
of chitosan to secondary amines upon coupling with the epoxide functional group of GPTMS, 
could be monitored. 
A standard curve was established with the batch of chitosan used in this study, which had an 
82% degree of deacetylation. It was compared to the chitosan coupled with GPTMS and showed 
that a 91% degree of crosslinking between chitosan and GPTMS was achieved. This high degree 
of coupling was closely monitored and maintained throughout the study, as variations in covalent 
coupling can yield large variations in the mechanical and thermomechanical properties of the 
resulting hybrid materials58. 
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Figure 3.4 Quantitative analysis of covalent coupling between chitosan and 3-
glycidyloxypropyltrimethoxysilane (GPTMS) by ninhydrin assay. In finely ground 
aqueous suspensions of coupled material (Ch+GPTMS) and uncoupled chitosan (MMW 
Chitosan), ninhydrin reagents selectivity for primary amines was measured by optical 
absorbance at 590 nm. The degree of covalent coupling between chitosan and GPTMS 
was measured to be 91% and maintained throughout the study. 
 
SEM was utilized to examine the roughened surface morphologies and microtopographies of the 
hybrid coating films (Figure 3.5A). A common standardized acid-etching protocol was applied to 
bare titanium to achieve a roughened substrate topography. To coat these roughened Ti6Al4V 
substrates, a dip coating protocol was utilized that has been shown to effectively deposit thin 
films from hybrid sols59–61. The thinness of the hybrid coating films ensured that there was a 
degree of roughness attributed to their acid-etched substrates. The coated surfaces retained a 
degree of microscale roughness that has been shown to provide a positive topographical stimulus 
for cell interactions and bone apposition62–64. 
The accompanying EDX analyses and elemental mapping of silicon, oxygen, nitrogen, carbon 
and silver (Figure 3.5B–F)) showed their distribution across the coated surfaces. All elements 
were found to be homogeneously distributed throughout the coating matrix for all samples. The 
distribution of silicon (Figure 3.5B) confirmed the presence of silanol and siloxane networks in 
the hybrid coatings and their homogenous nature throughout the matrix. The distribution of 
nitrogen (Figure 3.5D) and carbon (Figure 3.5E) confirmed the presence of an organic chitosan 
network that was homogenously integrated throughout the coatings. Additionally, the detection 
of silver (Figure 3.5F) confirmed the successful incorporation and homogenous distribution of 
antimicrobial AgNPs throughout the coating matrix. 
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Figure 3.5 Scanning electron microscopy (SEM) and elemental (EDX) analysis of the 40% 
ChSi-nAg hybrid coating. SEM showed smooth undulating contours and 
microtopographies (A). EDX mapping detected a homogenous distribution of silicon (B), 
oxygen (C), nitrogen (D), carbon (E) and silver (F). The SEM/EDX analyses were 
representative and consistent across all coatings. Scale bar: 100 µm. 
 
The AgNPs was synthesized through supplementary procedures. Their nanoscale dimensions 
were confirmed by transmission electron microscopy (TEM). Micrographs (Figure 3.6A) showed 
that all synthesized nanoparticles were under 100 nm in size and UV spectroscopy (Figure 3.6B) 
confirmed the consistency of their colloidal suspensions. The PVP-capped nanoparticles 
synthesized in this study, were maintained within 10–20 nm and exhibited long-term colloidal 
stability in aqueous solutions, before being incorporated into the chitosan–silica hybrid sol–gel 
system for coating. 
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Figure 3.6 Evaluation of synthesized AgNPs. (A) Transmission electron microscopy (TEM) 
confirmed nanoscale particle sizes. (B) UV spectroscopy of AgNP suspensions verified 
their consistency. 
 
Through the utilization of class II covalent coupling reactions, highly homogenous hybrid 
coatings were created. The homogenous coating matrices are consistent with enhanced 
mechanical properties. In contrast, coating materials that lack homogeneity have been shown to 
have inconsistent mechanical properties and result in areas across coating surfaces that have 
inconsistent resorption properties65,66. Indeed, a lack of homogeneity in the HA coating materials 
that are currently available has limited their clinical usage and success. They have been shown to 
suffer from phase inconsistency and resultant discrepancies in their mechanical properties67,68. 
ATR-FTIR analyses were used to compare the variation in chemical properties between different 
coating blends (Figure 3.7). For pure chitosan, the peaks associated with the stretching of the 
primary and secondary amines were identified at 1526 cm-1 and 1635 cm-1, respectively. As 
expected, these peaks decreased in intensity as the organic content of the hybrid coating blends 
decreased (80%, 60%, 40% and 20% ChSi), and were completely absent for the purely inorganic 
TEOS-based material. When comparing the intensity of these peaks for pure chitosan and the 
coupled chitosan samples (Ch+GPTMS), there was a decrease observed in the relative intensities 
for the primary amine in chitosan and no change for the secondary amine. This showed that the 
coupling reaction had only occurred between the primary amine in chitosan and GPTMS, 
confirming the findings of 13C MAS-NMR and the ninhydrin assay. 
Additionally, the incorporation of GPTMS into these hybrid materials was detected by the bond 
stretching associated with the epoxide group identified at 910 cm−1 (Figure 3.7). This epoxide 
peak was observed in pure coupled samples (Ch+GPTMS) and faintly in the more highly organic 
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blends (80% and 60% ChSi). As the inorganic fraction increased, this peak was progressively 
eclipsed by the consequent stretching of the silanol species at 935 cm-1. The incorporation of 
silane species into the hybrid coatings was observed as peaks from the stretching of the Si–OH 
bond at 774 cm-1 and 935 cm−1 in the hydrolyzed material and the stretching of the Si–O–Si 
bonds at 1065 cm-1 from condensed siloxane. As expected, the presence of these peaks became 
more prevalent as the organic content decreased in the hybrid coating blends. 
 
Figure 3.7 Infrared analyses of chemical structures in hybrid materials. Total reflectance Fourier 
transform infrared (ATR-FTIR) spectra of chitosan, chitosan coupled with 3-
glycidyloxypropyltrimethoxysilane (Ch+GPTMS), hybrid materials (80%–20% ChSi) 
and pure inorganic siloxane (condensed TEOS). There were more peaks attributed to 
chitosan and GPTMS (-NH, -NH2, Epox) for hybrid materials with higher organic 
content. Their chemical characteristics were more similar to a purely inorganic siloxane 
network (Si–O–Si, Si–OH), as the organic fraction decreased. 
 
3.3.2 Material Properties 
For all biomaterials, surface interactions with surrounding physiological fluids that may include 
the adsorption of serum proteins, are an important determinant of subsequent cellular responses 
and the ingrowth of host tissues69. To predict these interactions, the measurement of water 
contact angles on the biomaterial surfaces are an effective metric. Surfaces with contact angles 
64 
 
between 60° and 85° are intermediate in hydrophilicity, and have been shown to facilitate the 
most favorable interactions with host tissues through enhanced cell growth and 
proliferation59,70,71. 
All hybrid coatings that were developed in this study had an intermediate degree of 
hydrophilicity (Figure 3.8). The coating blend with the least organic content (20% ChSi) had the 
largest water contact angle and was a little more hydrophobic than the 60% ChSi blend, which 
had the smallest contact angle and was the most hydrophilic. However, these differences 
between the blends were small and not statistically significant (p > 0.05). However, all coatings 
had contact angles that were larger than their uncoated acid-etched Ti6Al4V substrate and these 
differences were statistically significant (p < 0.05). Although the coating blends contained many 
hydrophilic chemistries due to their chitosan content and the remaining silanol linkages, the bare 
acid-etched Ti6Al4V substrates had a high degree of surface roughness, which enhanced their 
wettability. For such wettable surfaces (contact angles < 90°), an increase in surface roughness 
has been reported to enhance their hydrophilicity72. The acid-etching of Ti6Al4V substrates 
created numerous pits and valleys ranging in size from 10–40 µm (Figure 3.9), which enhanced 
their surface roughness and thereby their hydrophilicity. The deposition of coatings on these 
substrates partially filled these pits and valleys, which reduced their surface roughness and 
increased water contact angles. 
 
 
Figure 3.8 Water contact angles for coatings and titanium (Ti6Al4V) substrates. Static water 
contact angles (n = 5/surface) for all coatings and polished Ti6Al4V were similar with an 
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intermediate degree of hydrophilicity. Contact angles for acid-etched Ti6Al4V were 
significantly (p < 0.05) lower and more hydrophilic. ns—not significantly different; *—
statistically significant difference. 
 
Figure 3.9 Scanning electron microscopy (SEM) of titanium (Ti6Al4V) substrates and coated 
surfaces. (A) Polished Ti6Al4V was flat with smoothly scalloped surfaces; (B) acid-etched 
Ti6Al4V had extensive surface fissures that created microscale roughness; (C) hybrid coating 
(60% ChSi) films on acid-etched Ti6Al4V substrates retained microtopographical features and 
surface roughness. SEM analyses were representative and consistent across all coatings. 
 
Biomaterial coatings also require adequate adhesive bond strength to their underlying substrates, 
which is an important parameter that is often overlooked in many studies. Poor adhesive strength 
may lead to delamination of the coating, which then causes inflammation, bone resorption, 
loosening of the fixtures and eventually the failure of intraosseous implants73,74. 
Initially, the adhesion of the hybrid coatings to Ti6Al4V substrates was evaluated by a cross-
hatch delamination protocol as described in ASTM D3359. This method provided a coarse 
assessment of overall coating adhesion. Additionally, the scoring of the coating materials 
imparted stresses within their structure, which manifest as extensive cracks and fissures across 
the surfaces of the purely inorganic controls (Figure 3.10C,D). The purely inorganic coatings 
were brittle, and cross-hatch testing had led to a widespread cracking of their thin films. In 
clinical applications, the impact of sharp boney protrusions and/or surgical instruments could 
lead to a premature failure of such coatings in vivo75. In contrast, all hybrid coatings exhibited 
highly robust, intact and integrated surfaces, despite the surface scoring (Figure 3.10A–B). 
Additionally, more rigorous and quantitative evaluations of coating adhesion and risk of 
delamination were performed by adhesive tensile tests based on established protocols55,76. All 
coatings were assessed for their adhesion to both polished and acid-etched Ti6Al4V substrates 
(Figure 3.11). All hybrid coatings were significantly (p < 0.05) more adherent to acid-etched 
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Ti6Al4V substrates than to polished titanium. Furthermore, all coating blends that contained 
AgNPs exhibited identical adhesion characteristics to those without these antimicrobial additives 
(excluded from figure to ensure clarity). As expected, acid-etching like other surface roughening 
pretreatments, enhances adherence to the modified substrate77–79. This has been attributed to the 
increase in bonding area by roughening pretreatments, which thereby enhance the mechanical 
adhesion of coatings to their substrates. However, purely organic chitosan control coatings 
showed only a small, statistically insignificant (p > 0.05) increase in adhesion to the acid-etched 
substrate compared to polished Ti6Al4V. This may have been due to the high viscosity of pure 
chitosan, which led to poor wetting of Ti6Al4V substrates, and lower overall mechanical 
adhesion compared to that of hybrid coating blends79. 
Among implant coating materials that are commercially available, plasma sprayed 
hydroxyapatite (HA) surfaces remain a gold standard for intraosseous applications. However, 
their preparations involve high temperatures and variable cooling cycles, which retain residual 
stresses that contribute to failures from adhesive forces of less than 10 MPa80–82. Therefore, the 
robust adhesion (16–18 MPa) for all hybrid coatings deposited on acid-etched Ti6Al4V that were 
developed in this research, warrant further study. 
 
 
Figure 3.10 Microscopic examination of coatings in cross-hatch tests of adhesion. (A,B) Coating 
(60% ChSi) surfaces were unblemished by full-depth incisions in the standardized cross-
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hatch adhesion protocol; (C,D) inorganic siloxane material (control) developed extensive 
arrays of surface cracks and fissures from the same cross-hatch testing protocol. 
Adhesion of the 60% ChSi coating blend was representative and consistent across all 
hybrid coatings. 
 
Figure 3.11 Adhesive tensile strengths of coatings and chitosan on titanium (Ti6Al4V) 
substrates. All hybrid coatings (n = 3/surface) had significantly (p < 0.05) more adhesion 
to acid-etched than to polished Ti6Al4V substrates. All hybrid coatings were more 
adhesive than pure chitosan to both polished and acid-etched Ti6Al4V. *—statistically 
significant difference 
 
3.3.3 Antimicrobial Properties 
As bacterial infections are the most common cause of implant failure7–9, the application of 
antimicrobial surface coatings may afford a valuable feature for implantable materials. 
Therefore, the coatings in this study were prepared with chitosan as the main organic constituent, 
which naturally displays some antimicrobial activity. Additionally, some of these coatings were 
loaded with AgNPs as additives that could further enhance their antimicrobial effects. 
Antimicrobial efficacies were evaluated on S. aureus and E. coli cultures, which are common 
Gram-positive and Gram-negative bacterial pathogens, respectively, associated with various 
bodily infections. 
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Interestingly, the S. aureus and E. coli cultures were only minimally affected by the base 
coatings that had not been loaded with AgNPs (Figure 3.12). However, E. coli growth was 
markedly reduced over 24 h, and S. aureus growth was completely suppressed for 24 h, with all 
coatings that contained AgNPs. 
 
Figure 3.12 Inhibition of bacterial growth in planktonic cultures. There was a (A) marked 
reduction in E. coli growth and (B) complete inhibition of S. aureus grown in the 
presence of 80% ChSi-nAg compared to 80% ChSi. This inhibition of bacterial growth 
by 80% ChSi-nAg was representative and consistent for all hybrid coatings that contained 
AgNPs. 
 
The quantitative assessments of these bacterial cultures following 24 h incubations with hybrid 
coatings showed that there had been some inhibition by all coatings, when compared to uncoated 
titanium controls (Figure 3.13). The planktonic E. coli and S. aureus cultures were almost 
completely inhibited (80%–100% and 75%–77%, respectively) by the presence of coatings that 
had been loaded with AgNPs. Indeed, coatings loaded with AgNPs were significantly (p < 0.05) 
more effective than base coatings without AgNPs, which had only minimal antibacterial effects 
(<30%). These results indicated that release-based mechanisms were involved in the 
antimicrobial properties of the hybrid coatings. They were bacteriostatic and/or bactericidal 
effects on some of the most common bacterial pathogens that cause opportunistic infections. 
Additionally, coatings loaded with AgNPs appeared to have been more effective against E. coli 
cultures, than S. aureus. This difference may have been due to the release-based antimicrobial 
action of AgNPs through the different cell wall structures of these bacteria. Unlike Gram-
negative E. coli planktonic cells, Gram-positive bacteria such as S. aureus are protected from 
their external environment by much thicker peptidoglycan layers within their cell walls83. These 
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cell walls may have partially limited the internalization of AgNPs and retarded their release-
based action. Similarly, previous studies have reported that Gram-negative bacteria experienced 
more membrane damage and oxidative stress in response to the release-based action of AgNPs, 
than Gram-positive bacteria84–86. 
 
Figure 3.13 Inhibition of bacterial cultures by hybrid coatings with (+) and without (−) AgNPs. 
(A) E. coli and (B) S. aureus cultures were inhibited by incubation (24 hours) with all 
hybrid coatings, compared to uncoated titanium (Ti6Al4V) controls. There was little 
inhibition from base coatings without AgNPs, but significantly (p < 0.05) more and 
almost total inhibition for coatings loaded with AgNPs. 
 
In addition to the virulence of planktonic cells within bacterial cultures, these pathogens can be 
particularly pernicious due to their formation of highly adherent biofilms on biomaterial 
surfaces. In contrast to cells suspended in culture, bacteria encased within biofilms are highly 
resistant to mechanical dislodgement and antibiotic treatment8,10. Therefore, E. coli and S. aureus 
biofilm formation on coatings were carefully compared to uncoated Ti6Al4V controls for 
inhibitory effects. 
Indeed, both E. coli and S. aureus were clearly inhibited for at least 24 h in their formation of 
biofilms on all hybrid coatings, compared to uncoated Ti6Al4V controls (Figure 3.14). Base 
coatings alone were moderately effective at inhibiting E. coli biofilm formation on their surfaces 
(31%–50%) and were even more effective against S. aureus (38%–80%). However, the coatings 
loaded with AgNPs were markedly more effective at inhibiting E. coli biofilm formation (60%–
95%), and almost completely effective against S. aureus (90%–95%). The coatings with AgNPs 
were significantly (p < 0.05) more effective than their unloaded controls for all blends, except 
those that had a high organic chitosan content. This accompanied the positive trend of greater 
antimicrobial activity with increasing chitosan content. As chitosan is a naturally antimicrobial 
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polysaccharide, its role in the coating network was expected to have had this effect on both the 
inhibition of biofilm formation and the inhibition of bacterial cultures87. 
The larger inhibition of S. aureus compared to E. coli biofilms contrasted with the reduced 
susceptibility of S. aureus than E. coli cells in culture. This may have been due to differences in 
their development of extracellular polymeric substances (EPS). Mainly composed of 
polysaccharides and proteins, the EPS produced by sessile colonies of bacteria has been shown 
to be a key component in their resistance to antibiofilm agents such as cationic peptides and 
metal ions88. Additionally, the EPS production of sessile colonies has been shown to be enhanced 
when colonies adhere to toxic surfaces89. Therefore, the sessile colonies of E. coli may have 
provided some resistance to the coatings by producing more EPS during biofilm formation. 
Indeed, prior studies have reported that E. coli exhibit rapid EPS formation when compared to 
their Gram-positive counterparts, leading to a more effective resistance in their sessile state84,90. 
 
 
Figure 3.14 Inhibition of bacterial biofilm formation on hybrid coatings with (+) and without (−) 
AgNPs. (A) E. coli and (B) S. aureus biofilm formation (24 h) were inhibited on all 
hybrid coatings, compared to uncoated titanium (Ti6Al4V) controls. Inhibition of biofilm 
formation was greater on coatings that contained AgNPs and was generally more on 
coatings with higher organic content. There was near complete inhibition of S. aureus 
biofilms on all hybrid coatings that contained AgNPs. 
 
3.4 Conclusions 
In this study, chitosan–silica class II hybrid materials were developed as thin film coatings for 
implantable Ti6Al4V surfaces. Additionally, the hybrid coatings were effectively loaded with 
AgNPs for antimicrobial applications. Their chemical structures and composition were 
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confirmed by MAS-NMR, FTIR and EDX analyses. Surface microtopographies, mechanical 
properties and wettability were evaluated by SEM, adhesive tensile testing and water contact 
angles. Antimicrobial properties were assessed in E. coli and S. aureus cultures and on their 
biofilm formation. 
The hybrid coatings demonstrated strong covalent linkages between their organic chitosan 
backbone and the silica inorganic network. There was a homogenous dispersion of elements, 
including AgNP additives, across their surfaces. Hybrid coatings demonstrated a robust 
resistance to fracture and dislodgement and were highly adherent to acid-etched Ti6Al4V 
substrates, especially when compared to purely organic or inorganic materials. They exhibited 
moderate levels of roughness, microtopography and wettability when compared with uncoated 
Ti6Al4V surfaces. All hybrid coatings displayed some antimicrobial effects and greater organic 
chitosan content was associated with increased bacterial inhibition. Additionally, coatings loaded 
with AgNPs showed marked inhibition of planktonic bacteria and their biofilms, with near 
complete inhibition of E. coli cultures and of S. aureus biofilm formation. These robust, retentive 
and antimicrobial coatings for implantable titanium materials were based on rudimentary 
chitosan–silica coupling processes, which may afford a novel strategy for biomaterial 
applications. 
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Chapter 4: Development of multifunctional bioactive implant 
coatings using a novel calcium precursor to improve 
osseointegration and antimicrobial effectiveness  
4.1 Introduction 
Over the past half century, titanium (Ti) and its alloys have become ubiquitous within 
implantology as materials of choice for augmenting and restoring function to human tissues1,2. 
They endure conditions of high-loading and/or repetitive cycling while remaining resistant to 
chipping and fracture, and possess the appropriate moduli that limit adverse effects from stress 
shielding seen with other metallic implant materials3–5. Addionally, the titanium dioxide layer 
that forms on the surface of these materials resists corrosion and provides a highly inert and 
biocompatible platform for interactions with surrounding cells and tissues. However, the inherent 
inertia of titanium surfaces is accompanied by a failure to alleviate two frequent complications in 
implantology. These are implant associated infections from surface microbes and aseptic 
loosening from lack of fixation, which pose major challenges to their long-term success and 
survival in clinical practice.  
Despite widespread use of aseptic surgical techniques, implant associated infections continue to 
pose a threat of complications to their integration and retention within host tissues. Currently, the 
risk of postoperative infections associated with hard tissue implantations range from 2-5% for 
orthopaedic procedures, and 4-11.5% for dental and oral surgeries6–8. They can be caused by any 
bacteria or fungi but are most commonly due to bacterial staphylococci. These include the 
common pathogen Staphylococcus aureus (S. aureus) and the ubiquitous Staphylococcus 
epidermidis (S. epidermidis)9,10 that are prevalent on human skin, and readily form biofilms on 
implant surfaces11. The biofilms consist of bacterial cells encased within their own 
polysaccharide matrix, which are highly adherent and resistant on biomaterial surfaces. As the 
biofilms mature they present a favourable environment for symbiotic microbes such as 
Escherichia coli and Pseudomonas aeruginosa to become established within polymicrobial 
communities12. These mature polymicrobial biofilms can be up to a thousand times more 
resistant to antibiotics than bacterial cells that are suspended in a planktonic state7,13. 
Accordingly, the infections require complex treatments that include complete removal of the 
implanted protheses and significant debridement of host tissues14. 
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Although implant associated infections are the primary cause of implant failures, the aseptic 
loosening of implants without microbial infections are another complication that occurs. Indeed, 
aseptic loosening may account for up to 36% of implant failures in joint arthroplasty15. These 
implants lack fixation and adequate osseointegration within host tissues16, and the resultant 
micromotions of the prosthesis may cause fibrous tissue formation, which exacerbates their 
loosening. Therefore, current strategies to enhance osseointegration are to promote bone 
deposition on implant surfaces with ceramic coatings containing calcium phosphates (CaP), 
hydroxyapatites (HA) and materials containing calcium, silica, phosphorous and magnesium 17–
20. However, these ceramic coatings are plagued by inconsistent properties from poor processing 
conditions that risk their delamination under clinical wear21,22.  
Therefore, implant surfaces need to both prevent infections and promote bone deposition to 
ensure success. Immediately following their surgical placement, both host tissue cells and 
contaminant microbes participate in a “race to the surface” of the biomaterial, where the fate of 
the implant is determined by which surface colonizers prevail12. Although current strategies may 
be effective at either goal, few are proficient in both domains. Therefore, multifunctional 
surfaces that both promotes bone apposition and prevent microbial colonization are sorely 
needed for implants. 
To develop such multifunctional implant coatings, the application of amorphous ceramic 
materials by using sol-gel techniques has shown promise. Sol-gel ceramic synthesis involves the 
hydrolysis and condensation of liquid ceramic precursors under low temperatures. The lower 
temperatures result in higher porosity and surface area for the materials compared to traditional 
melt-quench glasses, which promotes cell adhesion and tissue ingrowth23. Additionally, these 
solution-based low temperature preparations allow homogeneous loading of process-sensitive 
antimicrobials. Accordingly, such multifunctional sol-gel materials have been developed as 
beads/particles, scaffolds, and fibers24–26, but their inherent brittleness and poor adhesive tensile 
strength have limited their application as implant surfaces. Furthermore, the inclusion of calcium 
to induce apatite formation has not been successfully incorporated into these sol-gel 
preparations, under low temperatures or non-toxic synthesis conditions. 
The sol-gel ceramics mechanical properties can be improved by including organic polymers as 
composite and hybrid systems. However, simple blending of organic and inorganic networks 
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creates inhomogeneous sol-gel composites with mismatched degradation rates, which are 
unstable and deteriorate prematurely24,27. Alternatively, hybrid materials with molecular 
interactions between their organic and inorganic phases have significantly more stability than 
composites. Furthermore, hybrids with strong covalent interactions between organic and 
inorganic components (class II) have advantages over those with weaker molecular forces (class 
I).  These class II hybrids act as single-phase materials exhibiting improved mechanical 
properties and can be tailored to the needs of a variety of biomedical applications26,28–30.  
Sol-gel materials can be further enhanced by including calcium as an osteoconductive factor. 
Most commonly, calcium salts are added by high temperature processing in order to remove their 
toxic salt biproducts. However, such processing precludes the use of temperature-sensitive 
organic polymers and organosilanes such as GPTMS within hybrid sol-gel materials. Therefore, 
calcium alkoxides are now being investigated as precursors for the inorganic portion of sol-gel 
hybrid materials. They participate in the same network forming hydrolysis and condensation 
reactions as traditional silica precursors, which allows simple integration into sol networks at 
room temperature. However, most calcium alkoxides are highly sensitive to hydrolysis and 
condensation reactions in the presence of water. Their instability in aqueous systems leads to 
premature gelation of the inorganic network, which leads to poor and inhomogeneous integration 
of calcium into materials. Additionally, incompletely hydrolyzed calcium alkoxides can leach 
toxic by-products such as methanol from calcium methoxide and calcium methoxyethoxide. 
Accordingly, water-tolerant and non-toxic calcium alkoxides need to be explored. 
The purpose of this study was to develop robust multifunctional class II organic-inorganic hybrid 
coating materials for titanium implants. For the organic phase, PEG-amine was synthesized and 
coupled to GPTMS. The inorganic phase consisted of silica, and calcium was integrated into the 
sol-gel network with newly developed calcium 2-ethoxyethoxide (Ca2EE). Ca2EE, was stable in 
aqueous systems and homogeneously integrated into the hybrid coating network. These coating 
matrices were loaded with silver nanoparticles (AgNPs) that inhibited bacterial growth and 
biofilm formation. 
4.2 Materials and Methods 
All chemicals involved in the preparation of coating materials were purchased as laboratory 
grade reagents from Sigma Aldrich (St. Louis, MO, USA), unless otherwise specified. 
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4.2.1 Synthesis of Coating Materials 
Synthesis of Ca2EE 
Calcium-2-ethoxyethoxide (Ca2EE) was synthesized under similar conditions as other metallic 
2-ethoxyethoxides previously described31. Dry distilled 2-ethoxyethanol (Caledon Laboratories, 
Georgetown, ON, Canada) was heated to 80°C under an argon atmosphere. Calcium granules 
(Alfa Aesar, Tewksbury, MA, USA) were slowly introduced into the heated vessel through a 
pressure-equalizing funnel with maximal magnetic stirring. After adding metallic calcium, the 
vessel was heated to 125°C and left to react for 20 hours. Then, Ca2EE was purified by 
removing excess 2-ethoxyethanol through vacuum drying at 100°C for 6 hours. The Ca2EE 
structure was confirmed by 13C NMR and spectral data agreed with previous reports32. 
Functionalization of PEG 
Amine functionalized polyethylene glycol (PEG) was prepared for its capacity to covalently 
couple with inorganic silica networks as follows. PEG ditosylate (2k, 30g) was added to an 
ammonium hydroxide solution (105 mL, 7.5 M) and stirred at room temperature for 5 days. The 
resulting solution was washed (5x) with dichloromethane (5 x 100 mL), and the organic phase 
separated and dried over anhydrous magnesium sulfate, followed by concentration and 
precipitation with cold diethyl ether. The precipitate (PEG-diamine) was dried by vacuum 
filtration and collected as a white powder. The PEG-diamine structure was confirmed by 1H 
NMR and spectral data agreed with previous reports33,34.  
Silane coupling of PEG-NH2 
PEG diamine and 3-glycidyloxypropyltrimethoxysilane (GPTMS) coupling reactions were 
initiated by methods similar to those previously described 35–37. PEG-diamine was dissolved in 
absolute ethanol to a concentration of 40mg/mL. GPTMS was added to this solution at a ratio of 
1:2 of PEG-diamine to GPTMS and left to couple under an inert nitrogen atmosphere at room 
temperature for 24 hours.  
Synthesis of AgNPs 
Silver nanoparticles (AgNPs) were synthesized by a chemical reduction method previously 
described38–40. NaBH4 solution (2.0 x 10
-3 M) was prepared in double distilled water and placed 
in an ice bath for 15 minutes. Chilled NaBH4 was agitated by rapid magnetic stirring, and 
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AgNO3 solution (2.0 x 10
-3 M) was added dropwise at a ratio of 1:6 (v/v) of AgNO3 to NaBH4. 
Following the addition of AgNO3, the AgNP suspension was stabilized with 
polyvinylpyrrolidone solution (0.3wt%). AgNPs were extracted by ultracentrifugation and 
freeze-drying. 
Preparation of hybrid materials 
Class II organic-inorganic hybrid materials were synthesized with coupled PEG-NH2-GPTMS as 
the organic phase (20wt%) and Si/Ca as the inorganic (80wt%). The molar ratio of Si/Ca (70:30) 
matched that of traditional bioactive glasses. Tetraethoxysilane (TEOS) and HCl (1N) were 
added to double distilled water at a ratio of 10:1:3 (v/v) under an inert nitrogen atmosphere and 
allowed to react for 15 minutes. Si-functionalized PEG-NH2 was diluted in absolute ethanol and 
added to the hydrolyzed TEOS solution with stirring for 5 minutes. Then, freshly prepared 
Ca2EE was slowly added to the reaction vessel with rapid stirring over 40 minutes. After the 
addition of Ca2EE, antibacterial coating blends were loaded with AgNPs (0.023wt%) with rapid 
stirring for 10 minutes. 
 
Table 4.1 Composition of Si-Ca-PEG based coatings 
  Inorganic Bioactive Glass Hybrid Bioactive Glass 
Components Si-Ca2EE Si-Ca2EE-nAg Si-Ca-PEG Si-Ca-PEG-nAg 
TEOSa 70 70 56 56 
Ca2EEb 30 30 24 24 
PEG-
GPTMSc 
0 0 20 20 
AgNPsd 0 0.023 0 0.023 
a tetraethoxysilane (network wt%); b calcium-2-ethoxyethoxide (network wt%); c PEG-diamine coupled with 3-
glycidyloxypropyltrimethoxysilane (network wt%); d silver nanoparticles (total coating wt%) 
 
Deposition of Hybrid Coatings 
Ti6Al4V (9 x 9 x 2 mm) discs were prepared as substrates for the application of hybrid coatings. 
All discs were polished with silicon carbide paper up to 1200 grit. They were degreased and 
cleaned with acetone and deionized water by ultrasonication, and dried at 40°C. Additionally, 
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some discs were acid-etched by immersion in a HCl and H2SO4 solution (2:2:1 v/v) at 65°C for 
20 minutes. Following etching, discs were neutralized in a NaHCO3 solution (0.5 M) and cleaned 
as detailed above.  
Freshly prepared hybrid materials were deposited onto polished and acid-etched Ti6Al4V discs 
by using a standard dip-coating protocol41. The discs were dipped and withdrawn from hybrid 
solutions at a speed of 100 mm/min, dried in a vacuum oven at 80°C for 3 hours, and then stored 
at room temperature.  
4.2.2 Characterization of Coating Materials 
Hybrid coating materials were analyzed for their composition, chemical structures, and surface 
topographies. 
Chemical Structures 
Chemical structures were analyzed for the presence of bonds and key functional groups by using 
attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR). Hybrid 
materials were ground into a fine powder with mortar and pestle, and analyzed in a Bruker 
Tensor II system with a Platinum ATR (unit A225) equipped with a 2 x 2 mm diamond crystal 
(Brunker, Billerica, MA, USA). Spectra were acquired in the 4000-400 cm-1 range, at 4 cm-1 
resolution, averaged from 32 scans and analyzed using OPUS spectroscopy software.  
Surface Properties 
Surface morphologies and micro-topographies were examined by scanning electron microscopy 
(SEM), and elemental distributions were analyzed by energy-dispersive X-ray spectroscopy 
(EDX). The coated discs were affixed to metal stubs with carbon tape and sputter coated with 10 
nm gold nanoparticles. Coatings surface features were visualized using a Hitachi SU8230 
Regulus Ultra High-Resolution Field Emission SEM (Hitachi, Tokyo, Japan), and elemental 
mapping was obtained by from a Bruker X-Flash FQ5060 Annular Quad EDX detector (Brunker, 
Billerica, MA, USA). 
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4.2.3 Evaluation of Mechanical Properties 
Adhesive Strength 
Quantitative assessment of the hybrid coatings adhesion to titanium substrates was further 
evaluated using an established tensile adhesion protocol42. Briefly, coated Ti6Al4V discs were 
first secured to aluminum dollies using T-88 epoxy resin (System Three Resins, Inc., Lacey, 
WA, USA). Secured specimens were then seated in a tensile adapter in an Adelaide TCC 
universal testing machine (Adelaide Testing Machines, Toronto, ON, Canada), and slowly forced 
apart at a speed of 3 mm/min. Measurements for each coating and titanium surface treatment 
were tested in triplicate with the method of separation closely examined for the point of 
delamination. Using the load at failure and contact area of the aluminum dolly with the coated Ti 
disc, the adhesive strength of coating materials were calculated as: 
 
Adhesive Stength (MPa) =
Load at Failure (N)
Coated Area (m2)
 (1) 
 
4.2.4 Evaluation of Biological Properties 
Mineral Bioactivity 
Mineral bioactivities were evaluated by immersion of coatings in simulated body fluid (SBF), 
prepared as previously described by Kokubo et al43. For this preparation, NaCl, NaHCO3, KCl, 
K2HPO4·3H2O, MgCl2·6H2O, CaCl2 and Na2SO4 were dissolved in double distilled water and 
buffered to pH 7.4 using tris-(hydroxymethyl)-aminomethane ((CH2OH)3CNH2) and HCl. The 
resulting simulated body fluid solution had an ionic composition that was similar to that of 
human blood plasma (Table 2).  
 
Table 4.2 Ionic composition of simulated body fluid and human blood plasma 
[mM] Na+ K+ Mg2+ Ca2+ Cl- HCO3- HPO4
2- SO4
2- 
Body Fluid43 142 5 1.5 2.5 148.8 4.2 1 0.5 
Blood Plasma 142 5 1.5 2.5 103 27 1 0.5 
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Monoliths (100 mg) of coatings were immersed in 200 mL of simulated body fluid at 37°C for 
72 hours. Following immersion, coating monoliths were rinsed with ethanol and double distilled 
water and dried in a desiccator. Their dried surfaces were analyzed for the presence of 
crystallized apatite by using scanning electron microscopy (SEM) and energy-dispersive X-ray 
spectroscopy (EDX).  
Antimicrobial Efficacy 
The antimicrobial properties of base and AgNP loaded hybrid coatings were evaluated on 
common Gram-positive and Gram-negative bacterial pathogens. Their antibacterial effects 
against Staphylococcus aureus (Gram-positive, ATCC® 25923) and Escherichia coli (Gram-
negative, ATCC® 25922) in monocultures and within single species biofilms were assessed. 
Separate monocultures of E. coli and S. Aureus were prepared from inoculum and suspended in 
Luria Bertani (LB) media for growth.  
For these assessments, the coated Ti6Al4V discs were cleaned, disinfected and sterilized as 
follows. The coated discs were rinsed twice with ethanol (70% v/v), washed thrice with 
phosphate buffered saline (PBS), then placed in a tissue culture hood and exposed to UV light 
for 30 minutes to ensure sterility. For each assay, replicate coated discs (n=3/coating) were 
submerged in each bacterial suspension (105 CFU/mL) and incubated under aerobic conditions at 
37°C.  
To measure cell growth and survival in the planktonic state, samples of bacterial cultures grown 
around coatings were withdrawn after 24 hours. Diluted samples were measured for their 
absorbance (OD600) using a spectrophotometer (Agilent Technologies, Santa Barbara, CA). 
Following 24 hours of incubation, viable cells from bacterial suspensions were counted by serial 
dilution and the spread plate method using 100 x 15 mm LB Agar plates. 
To measure cell formation of biofilms, the coatings submerged within each bacterial suspension 
were withdrawn following 24 hours incubation. These coated discs were gently rinsed thrice with 
sterile phosphate buffered saline (PBS) to remove non-adherent cells and transferred to sterile 
culture tubes containing 2 mL of fresh LB media. They were then ultrasonicated for 5 minutes to 
dislodge adherent cells from biofilms. Viable bacteria from sonicated samples were harvested 
and counted by serial dilution and the spread plate method using 100 x 15 mm LB Agar plates.  
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The inhibition of bacterial growth by each coating for both non-adherent (planktonic) and 
adherent (biofilm) bacteria was calculated from the plate counts. Using the colonies for uncoated 
Ti6Al4V discs as the control (CFUcontrol) and the colonies counted for each hybrid coating 
surface (CFUcoating), bacterial inhibition was calculated as: 
 
 
Bacterial Inhibition (%) =
CFUContol − CFUCoating
CFUControl
× 100 (2) 
 
4.2.5 Statistical Analysis 
The data in this study were analyzed using GraphPad Prism software (V 6.01). All data are 
expressed as mean ± standard deviation. One-way ANOVA analyses were used to make 
comparisons among multiple groups. Group differences were specified using Tukey’s post hoc 
tests with the differences considered statistically significant when p < 0.05. 
4.3 Results and Discussion 
4.3.1 Characterization of Coating Materials 
Hybrid precursor identification and synthesis 
The first step in this work was to identify and synthesize an appropriate calcium alkoxide 
precursor for use within the bioactive glass network. Indeed, the use of calcium alkoxides have 
been shown to enable successful integration of calcium into silicate networks at low 
temperatures 44. Calcium 2-ethoxyethoxide (Ca2EE) was identified as a potential calcium 
precursor due to its structural stability in aqueous environments and non-toxic degradation by-
products. Most previously investigated calcium alkoxide precursors, such as calcium 2-
methoxyethoxide (CME), have been unstable in sol-gel systems containing water, which can lead 
to poor hybridization and premature gelation of network structures 45–47. Despite the relative 
instability of CME, promise exists in the use of similar longer ligand Ca-2-alkoxyalkoxides as 
they are able to form water-stabilizing chelate cycles enabled through the presence of their 
secondary ether group31. Along with their sensitivity to water, previously used calcium alkoxide 
precursors have possessed the potential to leach toxic degradation by-products from bioactive 
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glass materials. For example, calcium precursors such as CME and calcium methoxide (CM) 
have the potential to leach methanol from bioactive glass materials if their ligands remain 
uncondensed during network formation which could elicit a degree of cytotoxicity. Ca2EE, if left 
uncondensed within bioactive glass materials, could instead leach ethanol, mitigating the 
potential for a developed bioactive glass material to exhibit toxicity in vivo. 
While this compound has been synthesized in previous works, it has not yet been utilized as a 
network precursor for bioactive glass materials. One of the primary reasons for this is that 
traditional methods for synthesizing calcium-2-ethoxyethoxide required the use of a toxic 
catalyst (mercury (II) chloride), rendering the material unsuitable for biological applications48. In 
this study, Ca2EE was synthesized in the absence of mercury (II) chloride to enable its use 
within bioactive glass materials. Using 13C NMR, the successful synthesis of Ca2EE was 
confirmed through observation of the pronounced deshielding of the Ca-O adjacent carbon 
compared to that of the parent alcohol (2-ethoxyethanol) (Figure 4.1). Addionally, the doublets 
appearing at C-1 and C-3, characteristic of bridging and non-bridging carbon resonances, further 
confirmed the synthesis of Ca2EE, and were consistent with that of previous work32. 
 
Figure 4.1 13C NMR of synthesized calcium-2-ethoxythoxide (Ca2EE) 
The next step in this work was to identify and synthesize an appropriate organic polymer for use 
within the hybrid bioactive glass network. Hydrophilic organic polymers have often been 
identified as ideal class II precursors due to their ability to improve the flexibility of hybrid 
89 
 
materials and improve their ability to participate in ion exchange with physiological fluids. For 
this reason, poly(ethylene) glycol (PEG) was identified as the ideal given its flexible solubility 
parameters and well established biocompatible and bioresorbable nature 29,49. To be successfully 
integrated into the hybrid network, PEG was amine-functionalized to enable its coupling to a 
silane precursor. Amine functionalization was selected due to the well-established coupling 
reaction between amine-bearing polymers through the epoxide of GPTMS 30,50. The synthesis of 
PEG-diamine was confirmed though 1H-NMR (Figure 4.2). 
 
 
Figure 4.2 1H NMR of synthesized PEG-diamine (2K) 
 
Hybrid Bioactive Glass Synthesis 
In this study, class II hybrid bioactive glass materials were developed using PEG-diamine as an 
organic polymer component, GPTMS as a silane coupling agent, Ca2EE as a calcium source, and 
TEOS as an inorganic silicate networking agent. Initially, covalent coupling occurred between 
the epoxide functional group of GPTMS and the primary amine groups of PEG-diamine (Figure 
4.3(1)). Additionally, during the acidic conditions of this reaction, the ethoxysilane bonds of 
GPTMS were hydrolyzed to form Si-OH pendants.  Following coupling, silane-functionalized 
PEG-diamine was added to a pre-hydrolyzed solution of TEOS to homogenize. Shortly after the 
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addition of silane-functionalized PEG-diamine, Ca2EE was added slowly to the reaction vessel 
to allow for the covalent introduction of calcium and continued polycondensation of the silicate 
network. Following the reaction of the above-mentioned reagents, antibacterial coating materials 
were developed through the simple addition of PVP-stabilized AgNPs. 
 
 
Figure 4.3 Chemical synthesis of PEG–Ca-silica Class II hybrids and imbedding of silver 
nanoparticles (AgNPs). (1) Coupling of PEG-amine and 3-
glycpidyloxypropyltrimethoxysilane (GPTMS) in mildly acidic conditions; (2) 
polycondensation of coupled PEG-amine, calcium 2-ethoxyethoxide, and hydrolyzed 
tetraethoxysilane (TEOS); (3) imbedding AgNPs into the hybrid sol network. 
 
For synthesized PEG-diamine, it was important to identify the characteristic organic portions of 
the polymer (Figure 4.4). The primary amines present in the structure were identified at 1570cm-
1 and the associated -CH backbone bending was identified at 1466cm-1. Upon coupling with 
GPTMS, the peak attributed to the primary amine of PEG-diamine diminished, as coupling 
proceeded between the two components to establish secondary amine linkages. Complete 
organic-inorganic bioactive glass materials composed of coupled PEG-diamine, calcium, and 
silica sol-gel precursors possessed decreasing characteristics of the organic PEG-diamine. This 
led to the reduction in both -NH2 and -CH bending and the broadening of peaks associated to the 
inorganic network such as Si-OH (780, 934 cm-1) and Si-O-Si (1065 cm-1). As expected, both 
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completely inorganic materials composed of both bioactive glass and pure silicate networks did 
not possess any peaks attributed to the inorganic network. Differences between the two networks 
can be observed through their degree of condensation. The purely silicate network (formed by 
hydrolyzing and condensing TEOS) had a stronger peak attributed to the condensed silicate 
species (Si-O-Si). Indeed, this was expected as the calcium alkoxide used in this study (calcium 
2-ethoxyethoxide) has fewer terminal sites (2) compared to that of TEOS (4). The integration of 
Ca2EE was thus expected to decrease the network density, which has been well established to 
also affect the dissolution rate of the inorganic bioactive glass materials41. 
 
 
Figure 4.4 Infrared analyses of chemical structures in Si-Ca coating materials. Total reflectance 
Fourier transform infrared (ATR-FTIR) spectra of PEG-diamine, PEG-diamine coupled 
with 3-glycidyloxypropyltrimethoxysilane (PEG+GPTMS), hybrid coating material (Si- 
Ca-PEG), inorganic bioactive glass material (Si-Ca), and pure inorganic siloxane 
(condensed TEOS). Peaks attributed to PEG-diamine (-NH2, -CH) were apparent for the 
hybrid coating material and absent in purely inorganic coating materials. The chemical 
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characteristics of the inorganic bioactive glass coating materials was similar to that of the 
pure siloxane network with prominent Si-O-Si and Si-OH peaks. 
 
 Coating adhesion is an important factor in determining the clinical translatability of implant 
coating materials. While overlooked in many studies, poor adhesive strength may lead to 
delamination of coating materials which can cause inflammation, bone resorption, and to the 
eventual failure of intraosseous implants in vivo51,52.  
To quantitatively evaluate the adhesion of the hybrid bioactive glass coatings developed in this 
study, adhesive tensile tests were performed based on established protocols42,53. Coatings were 
evaluated for their adhesion to both polished and acid-etched Ti6Al4V substrates (Figure 4.6). 
Hybrid bioactive glass coatings were significantly (p < 0.05) more adherent to acid-etched 
Ti6Al4V than to polished Ti6Al4V substrates. Indeed, acid-etching, as with other surface 
roughening pre-treatments, has been well established to increased the adherence of coating 
materials54–56. This improvement in coating adhesion has been attributed to greater mechanical 
adhesion due to the increase in bonding area that occurs during roughening pre-treatments. 
While plasma-sprayed hydroxyapatite (HA) coating materials remain the gold standard for 
intraosseous implants, their relative inconsistency and weakness has been the subject of many 
studies. Their application, which include high temperatures and variable cooling cycles, are 
known to retain residual stresses within these coating materials which can result in adhesive 
failures below 10 MPa21,57,58. The robust adhesive characteristics of the developed hybrid 
bioactive glass coating (15.1 ± 3.3 MPa) developed in this study, therefore, warrants further 
study.  
 
Figure 4.5 Scanning electron microscopy (SEM) of titanium (Ti6Al4V) substrates and coated 
surfaces. Polished Ti6Al4V was flat with smoothly scalloped surfaces (A). Acid-etched 
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Ti6Al4V had extensive surface fissures that created micro-scale roughness (B). Hybrid 
bioactive glass coating (Si-Ca-PEG) films on acid-etched Ti6Al4V substrates retained 
micro-topographical features and surface roughness (C). 
 
 
 
Figure 4.6 Adhesive tensile strengths of coatings and chitosan on titanium (Ti6Al4V) substrates. 
Hybrid bioactive glass (Si-Ca-PEG) coatings (n=3/surface) were significantly (p < 0.05) 
more adherent to acid-etched Ti6Al4V substrates than they were to polished Ti6Al4V.* - 
statistically significant difference 
 
4.3.2 In Vitro Bioactivity 
The promotion of bone growth is important in ensuring the fixation of metallic implants and 
preventing events of aseptic loosening. Calcium integration within coating materials has been 
identified as a key factor in the development of bioactive materials21,22. It was therefore 
important to determine whether the low temperature integration of Ca2EE into the hybrid sol-gel 
coating networks would render the hybrid coatings to be bioactive.  
Evaluation of osteoconduction through in vitro immersion studies has been well established to be 
indicative of actual osteoconduction and bone growth in vivo59,60. Therefore, in this study, the 
mineralization of HA on hybrid coating surfaces was evaluated following 72 hours immersion in 
simulated body fluid (SBF). To evaluate HA mineralization on hybrid coating materials, SEM 
analysis and EDX maps were used (Figure 4.7). Following 3 days immersion in SBF, 
characteristic globular HA deposits were found on the surface of hybrid coating materials 
94 
 
(Figure 4.7-a). Indeed, EDX mapping confirmed the composition of globular deposits to be 
hydroxyapatite through the presence of phosphate on the surface (Figure 4.7 (f)), and, the 
elemental ratio of Ca/P of 1.6. While the elemental ratio of Ca/P is slightly below the theoretical 
value of hydroxyapatite (Ca/P = 1.67) it is well within that of common apatite crystallites formed 
by similar biomimetic processes61,62.  
Further, EDX analysis confirmed the retention and homogeneous distribution of coating network 
elements and imbedded AgNPs (Figure 4.7 b-e). Following 72 hours immersion, AgNPs 
remained imbedded within the coating network and were not lost to dissolution. 
 
 
Figure 4.7 Elemental EDX mapping analysis of the hybrid coating material (Si-Ca-PEG) after 
72 hours immersion in SBF: (a) selected microscopic SEM field; (b) Si; (c) C; (d) Ag; (e) 
Ca, and (f) P. SEM micrographs display the presence of apatite globules on the surface of 
Si-Ca-PEG monoliths following immersion in SBF. Elemental analysis confirms the 
presence of apatite. Scale bar: 100 µm. 
 
4.3.3 Antimicrobial Properties 
Infections due to microbial colonization on implant surfaces currently pose the highest risk to the 
success of implantable prostheses6–8. Therefore, the application of antimicrobial coatings on 
implant materials presents an effective strategy in mitigation IAIs.  
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Further, the utilization of AgNPs within antimicrobial materials has garnered significant interest 
due to their broad-spectrum effects, limited cytotoxicity, and ease of synthesis63,64. AgNPs 
possess particular advantages as coating-loaded antimicrobial agents as they have shown efficacy 
in mitigating the growth of bacteria in both static and planktonic cultures65–67.  
Therefore, in this study, hybrid coatings were afforded with antimicrobial properties by 
imbedding AgNPs within the hybrid coating networks. S. aureus and E. coli, clinically relevant 
pathogenic bacteria, were selected as model bacterium to evaluate the antimicrobial efficacy of 
developed coatings. The efficacy of such antimicrobial coatings was evaluated in both culture 
and biofilm states.  
In planktonic assays, hybrid coatings loaded with AgNPs showed effective inhibition of both 
bacterial cultures compared to uncoated titanium controls (Figure 4.8). Both planktonic cultures 
of E. coli and S. aureus were almost completely inhibited (90% and 82%, respectively) by hybrid 
coating materials loaded with AgNPs and were significantly (p < 0.05) more effective in 
mitigating microbial growth than base coatings (< 6%). Given the suspended nature of the 
culture, these results indicated that imbedded AgNPs participated in release-based antimicrobial 
action against both pathogenic bacteria.  
Coating materials loaded with AgNPs, while effective at mitigating the growth of both model 
bacteria in planktonic cultures, displayed greater efficacy against E. coli than S. aureus. The 
differences in antimicrobial efficacy against both pathogenic bacteria can be owed to the 
differences between Gram-negative and Gram-positive cell wall structures. Gram-positive 
bacteria, such as S. aureus, possess much thicker peptidoglycan layers within their cell walls 
compared to Gram-negative bacteria such as E. coli68. The thicker cell walls of Gram-positive 
bacteria have been shown to limit the internalization of antimicrobial nanoparticles, and, have 
shown a reported similar resistance to such antimicrobials compared to Gram-negative 
bacteria69–71. 
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Figure 4.8 Inhibition of bacterial cultures by Si-Ca-PEG coatings with (+) and without (−) 
AgNPs. E. coli and S. aureus cultures were inhibited by incubation (24 hours) with 
AgNP-loaded hybrid coatings, compared to uncoated titanium (Ti6Al4V) controls. There 
was little inhibition from base coatings without AgNPs, but significantly (p < 0.05) more 
and almost total inhibition for coatings loaded with AgNPs.  
 
Due to the highly resistant nature of biofilms, their treatments remain minimally effective in the 
clinic. For this reason, antimicrobial coatings are continuously sought to enable the localized 
dislodgement or inhibition of biofilms on implant surfaces. Therefore, in addition to their 
efficacy against suspended bacteria, hybrid coatings were assessed for their ability to mitigate the 
formation of E. coli and S. aureus biofilms.  
Both E. coli and S. aureus cultures were effectively inhibited by hybrid coatings containing 
AgNPs compared to their uncoated Ti6Al4V controls (Figure 4.9). The biofilms formed by E. 
coli and S. aureus were markedly inhibited (80% and 89%, respectively) by hybrid coatings 
materials loaded with AgNPs and were significantly (p < 0.05) more effective at preventing 
biofilm formation compared to base coatings (< 25%). Such results indicate the contact-active 
and anti-adhesive nature of hybrid AgNP-loaded coatings against model sessile bacteria colonies.  
In contrast to planktonic susceptibility, E. coli was less susceptible than S. aureus to 
antimicrobial coating blends during biofilm assays. While these differences were insignificant 
(p > 0.05) in our study, similar works have also found E. coli to be more resistant than other 
Gram-positive bacteria to antimicrobial coatings in biofilm assays69,72. Such differences have 
been owed to the rapid extracellular polymeric substance (EPS) formation of E. coli in their 
sessile state, which has shown to be effective in resisting antibiofilm agents such as metal ions73.  
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Figure 4.9 Inhibition of bacterial biofilm formation on hybrid coatings with (+) and without (−) 
AgNPs. E. coli and S. aureus biofilm formation (24 hours) were inhibited on hybrid 
coatings, compared to uncoated titanium (Ti6Al4V) controls. Inhibition of biofilm 
formation was significantly greater (p < 0.05) on coatings that contained AgNPs. Hybrid 
bioactive glass coatings were generally more effective than purely inorganic bioactive 
glass coatings at inhibiting the formation of biofilms. The highest degree of biofilm 
inhibition was observed for S. aureus biofilms on for both coatings that contained 
AgNPs. 
 
4.4 Conclusions 
In this study, Si-Ca-PEG class II hybrid materials were developed as coating materials for 
implantable Ti6Al4V substrates. To manifest antimicrobial properties, developed coatings were 
loaded with AgNPs. Using 13C and 1H NMR, the synthesis of new precursor components was 
confirmed. The chemical structure and topographies of developed coating materials was 
evaluated using FTIR, SEM and EDX analysis. To evaluate the robustness of developed hybrid 
coatings materials, adhesive tensile testing was preformed. The in vitro bioactivity of hybrid 
coatings was assessed through their immersion in SBF and ability to induce the nucleation of 
HA. The antimicrobial properties of developed coatings were evaluated in planktonic and 
biofilm cultures of E. coli and S. aureus.  
Coating precursors, including Ca2EE and PEG-diamine, were introduced into a hybrid bioactive 
glass network for the first time. Their synthesis was confirmed using through the analysis of 
relevant NMR data and consistency with relevant literature. Hybrid bioactive glass coatings 
demonstrated robust resistance to delamination and were highly adherent to Ti6Al4V substrates. 
Ti6Al4V substrates that were acid-etched demonstrated retained microtopographical roughness 
and increased resistance to hybrid coating delamination. Hybrid coatings were able to promote 
apatite mineralization in vitro, indicative of their potential to rapidly promote new bone 
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regeneration and fixation in vivo. Additionally, hybrid coating materials loaded with AgNPs 
showed significant inhibition of E. coli and S. aureus in both planktonic and biofilm states. The 
highly adherent and multifunctional hybrid coating materials developed in this study affords a 
novel strategy in mitigating the risks associate with implantable titanium materials.   
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Chapter 5: General Discussion 
5.1 Summary 
The main objective of this study was to develop bioactive and biocompatible covalently coupled 
(class-II) hybrid coating materials to mitigate the complications associated with titanium 
implants. In this thesis, the synthesis and evaluation of two coatings systems were discussed.  
First, in chapter 3, the synthesis of chitosan-silica hybrid coatings prepared through sol-gel 
processing were presented. In this study, the inorganic network was composed exclusively of 
silica and the organic network materials were comprised 3-glycidoxypropyl trimethoxysilane 
(GPTMS) and chitosan. Developed hybrid coatings possessed improved robustness to control 
inorganic silica coatings which have previously been shown to be brittle when cured at low 
temperatures. Additionally, upon acid-etching Ti6Al4V substrates, all hybrid coatings possessed 
improved adhesive properties and outperformed some clinically available hydroxyapatite-based 
implant coating materials. By loading these hybrid materials with silver nanoparticles, coated 
substrates were able to provide an effective resistance against both E. coli and S. aureus in 
culture and adherent states.  
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In chapter 4, the synthesis of novel polyethylene glycol-diamine-calcium-silica coatings prepared 
through sol-gel processing were presented. In this study, the inorganic network was composed of 
silica and newly synthesized calcium-2-ethoxyethoxide (Ca2EE) to afford the material with 
greater bone-bioactivity. Here, the organic network was comprised of 3-glycidoxypropyl 
trimethoxysilane (GPTMS) and PEG-diamine (2K). In this work, we provided a non-toxic 
synthesis method for developing Ca2EE which has not yet seen use in the development of other 
bioactive glass materials. The room temperature addition of calcium into the hybrid coating 
network was successfully achieved using this new calcium alkoxide and promoted apatite 
mineralization in vitro after only 3 days immersion in simulated body fluid (SBF). Developed 
hybrid coatings were highly adherent to acid-etched Ti6Al4V substrates and outperformed that 
of some clinically available hydroxyapatite-based implant coating materials described in other 
studies. By loading these hybrid materials with silver nanoparticles, coated substrates were able 
to provide effective antimicrobial action against both E. coli and S. aureus in both culture and 
adherent states.  
5.2 Contributions to current knowledge 
For metallic implants, the synergistic risks of loosening and infection have been well established 
since the 1980s1. Despite this, aseptic loosening and implant associated infections continue to 
plague hard tissue implants and limit their success in the clinic. In this thesis work, we provide 
two feasible coating systems which can be utilized to improve the success of metallic implants.  
In the study of both coating materials, delamination protocols were followed to better evaluate 
the robustness of the developed hybrid coating materials. Such tensile adhesion pull-tests have 
not yet been preformed on similar hybrid materials to the ones described in this work. These 
results can provide a much-needed baseline to assess the robustness of other such coatings which 
may be used for metallic implant materials.  
This study also evaluated the contact and release-based antimicrobial action of silver 
nanoparticles imbedded within hybrid coating materials. While other studies typically assess the 
antimicrobial action of such coatings through either release-based (Kirby-Bauer) or contact-
based (biofilm) assays, we evaluated the antimicrobial action of our coating in both domains. 
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These results will ideally emphasize the importance of both antimicrobial strategies in the 
development of effective antibacterial implant coatings.  
Lastly, in chapter 4, the novel non-toxic synthesis of calcium-2-ethoxyethoxide (Ca2EE) is 
proposed, and, for the first time, used in the synthesis a bioactive glass material. In this work, 
synthesized Ca2EE displayed stability in water-containing sol-gel systems and was able to be 
homogeneously introduced into hybrid coating material networks at low temperatures. By 
providing the synthesis and network integration protocol for Ca2EE, other researchers may use 
this sol precursor to develop other bioactive materials that can be cured at low temperatures, 
enabling the inclusion of temperature sensitive components.   
5.3 Limitations and Suggestions for Future Work 
Through this work, sol-gel derived hybrid coatings on Ti6Al4V substrates were preliminarily 
examined. While the materials developed in this study displayed favourable results in improving 
the lifetime of metallic implants, more experimental works are suggested before this coating 
technology could be transferred to the clinic. Therefore, the following limitations of this study 
are discussed below, with appropriate recommendations for future works.  
While coated substrates displayed a high degree of robustness and resistance to delamination, 
more detailed experimentation could be conducted to further evaluate the physical properties of 
coating materials. For example, the thickness of the coating materials could be further evaluated 
using advanced SEM/TEM techniques to better evaluate the effect of dipping speed, the 
adherence characteristics of modified coatings, and the effect of relevant substrate pre-
treatments. Additionally, as roughness and porosity are important parameters in determining the 
cellular response to biomaterials, quantitative measurements to evaluate coating topographies 
(such as atomic force microscopy) should be used in place of the qualitative SEM descriptions 
provided in this work. Lastly, while the robustness of developed coating materials was evaluated 
in a quantitative manner, additional clinically relevant assessments could be preformed. For 
example, the resistance of coating materials to fracture or delamination in a more clinical setting 
could be evaluated by coating titanium dental screws and preforming pseudo-implantation and 
removal in a model bone material2. 
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Another limitation to this study is the absence of release and degradation-based data of 
developed coating materials. For future works it is recommended that elemental release data be 
collected (using inductively coupled plasma mass spectroscopy) in relevant solutions (preferably 
simulated body fluid). This data could be used to better evaluate how the hybrid coating 
materials degrade, and, assess if there is any inhomogeneous degradation of coating components. 
Additionally, using ICP-MS, the mineralization of apatite on hybrid coating surfaces could be 
quantified over time which could be used to compare the in vitro bioactivity of a variety of 
modified and control surfaces.    
Lastly, one major limitation to this study is that cell culture or in vivo studies were not preformed 
on developed coating materials. Although developed coatings displayed favourable signs for cell 
viability (microroughness, hydrophilicity, etc.), relevant cytotoxicity and proliferation assays 
should be preformed to better assess their in vivo compatibility. In general, cell attachment and 
proliferation studies are necessary to determine the cellular metabolic activity and osteoinductive 
of developed hybrid coatings to ensure that they are indeed biocompatible3.  
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